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INTRODUCTION  
 Siddha system – The time honoured medicine which has been prevalent of yore is 
the foremost of all medical system in world. 
 
 The word Siddha comes from the word Siddhi which means an object to be attained 
perfection or heavenly bliss. It generally refers to the ―Attamasiddhi‖ (i.e.) the eight 
supernatural powers. Those who attained these powers are called as Siddhars. 
 
 As the siddha medical works were authorised by the great Siddhars, they are 
considered excellent. These medical works were bestowed by the great Siddhars, after 
attaining spiritual knowledge through physical perfection and spiritual salvation, as 
explained by the saint YUGI in the following verse: 
 
―milthd Mas;Nt je;jd; idj;jhd; 
 IaUNk mk;ikjdf; fUspr; nra;a 
eilthd mk;ikAk;ee; jpf;Fr; nrhy;y 
 ee;jpAk; rPlh;fSf; fUspr; nra;aj; 
jilthd jd;te;jhp mRtp dpf;Fr; 
 rkurkhk; mfj;jpaKdp Njiu ah;f;F 
eilthd hp\pNjth; nrhd;d Ehypd; 
 Neh;iknay;yhk; tptukha; epfo;j;jp NdNd‖. 
 
 The works were passed on Lord Shiva to his consort and then to Nandhi, who in 
turn taught to Dhanvantari, who in turn to Aswini Devas, the twins and they narrated these 
works to Agathiar. Agathiar in turn told to saint Theraiyar and finally Theraiyar narrated 
these to Rishi Devar. The present form of medical works is adapted from the works of Rishi 
Devar. 
 According to Siddha medical science, the universe originally consisted by atoms 
which contributed to the five basic elements, viz., Nilam (earth), Neer (water), Thee (fire), 
Vali (wind) and Veli (space) which synchronise with the five senses of the human body, and 
they were the fundamentals of all the corporal things in the world. A close relationship is 
found existing between the external world and the internal system of human body. Siddhars 
maintain that the structure of the human body is a miniature of the world in itself. In other 
words, every substance visible or invisible, animate or inanimate is said to be formed of 
kinds of Panchaboothas, otherwise called the five elements which is said above. They might 
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have been formed by one, two, three, four or five elements noted above. This is the first 
principle or idea of a substance. 
 
Also SATTAMUNI GNANAM says that, 
  ―Microcosm reflects macrocosm‖ 
  ―mz;lj;jpYs;sNj gpz;lk; 
  gpz;lj;jpYs;sNj mz;lk; 
  mz;lKk; gpz;lKk; xd;Nw 
  mwpe;Jjhd; ghh;f;Fk; NghNj‖ 
     - rl;lKdp Qhdk;. 
 
(i.e.) The universe is a macrocosm made up of five primordial elements or boothas 
and the human being is a microcosm made up of the same five elements. 
 
 The seers of ancient India propounded the Thiridhatu theory in accordance with 
which three vital elements namely the Vatha, Pitha and Kaba in their normal condition 
regulate all physiological activities and keep the body healthy. This Thiridhatu theory is 
also based on Panchaboothas. 
 
 When these Thridhatus became abnormal or when their mutual harmony is disturbed 
they bring about ill health. It is mentioned in Thirukural as follow, 
 
  ―kpfpDk; FiwapDk; Neha;nra;Ak; EhNyhh; 
  tsp Kjyh vz;zpa %d;W.‖ 
- jpUts;Sth;. 
 
 Siddha differs from western system of medicine in the method of approach to the 
medical problems which it views and interprets in terms of the three elemental theories and 
thus while considering the aetiology and treatment of disease, it gives more attention to the 
disorders of the body than to the extrinsic ones. A specific feature in Siddha care is the 
Kalpamurai also called as Kayakalpa where the human body can be fortified into rock like 
strength through serious of efforts with lifestyle, strengthening drugs and formulations. 
 The uniqueness of Siddha system of medicine is not only curing the ailments but 
also the mind to lead a peaceful life. In Thirukurral, it is stated as, 
  ―kdeyk; kd;Daph; fhf;Fk;‖ 
- jpUts;Sth; 
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 The words of the Siddhars are indeed difficult to interpret and to be translated 
effectively in a foreign medium. It has been described that the number of diseases comes up 
to 4448. They have classified them as those affecting the different part of the body. Out of 
4448 Skin diseases are 90 and Kuttam (Leprosy) is 18. According to our Siddha literature 
Venpulli (Vitiligo) comes under the 18 types of Kuttam. It is also called as Venkuttam, 
Venpadai and Suvetha kuttam. 
 
 Venpulli (Vitiligo) is a skin disorder in which there is focal failure of pigmentation 
may be in defined area or as dots in skin with or without the hair depigmentation. Last 
decade has witnessed an increasing interest in psychological effects and quality of life in 
patients suffering from this disease. A healthy normal skin is essential for a person‘s 
physical and mental well-being. It is an important aspect of their sexual attractiveness, a 
sense of well-being and a sense of self confidence. Hence any blemish on the skin visibly 
affects the person‘s onlooker and thus the patients affected profoundly. 
 
 It affects the general population worldwide with a variable frequency ranging from 
0.38% to2.9%.42% male and 58% female, aged predominantly between six and ten years 
old (40%) were studied at the Martagao Gesteira Childcare and Pediatrics Institute between 
2005 and 2011.Both the sexes were equally affected. Vitiligo‘s onset being most between 
the age of 40-60. About 50% of all patients with vitiligo have an onset before 18 year of age 
and 25% develop depigmentation before age 8. 
 
 Vitiligo is more acute in the case of young women and children. In India vitiligo 
commonly known as Leucoderma is unfortunately associated with some religious beliefs. It 
is believed that the person who did ―Guru Droh‖ in his/her previous life suffers from 
vitiligo in this life. Many vitiligo patients feel distressed and stigmatized by their condition. 
They attract undue attention from the general public sometimes whispered comments, 
antagonism and ostracism. The self-image of the vitiligo patients drops considerably and 
may lead to depression. These patients often develop negative feeling about it. It may be 
embarrassing and the frustration of resistant lesions over exposed part of hands and feet can 
lead to anger and disillusionment.  
 
 In Siddha medicine child care has been considered so important that it is classified 
and subdivided into further branches depending on the age starting from early infancy to 
late childhood. Balavagadam is the branch of medical science of Siddhars which deals with 
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the diseases of children, their essential nature, especially on the functional changes together 
with planetary influence, morbid diathesis etc. on the treatment. 
 
In NIS OPD a considerable number of patients in paediatric population are recorded 
with symptoms of Venpulli. Children are not aware of this condition because this doesn‘t 
cause any illness to them. But it may lead to a complex comparing to others skin 
complexion in the schools and their surrounding environment. They may be mentally 
affected and feel shy which reflects in their academic, attitude and in their performance 
skill.In Siddha vaithiya thirattu text, there is a preparation called Parangipattai Chooranam 
which has Venpulli as its indication. So, I wish to evaluate its efficacy as my dissertation 
work in our OPD and IPD patients in National Institute of Siddha, Chennai. Also we are 
suggesting Annabedhi Chenduram mixed with lemon juice as an external application along 
with OP medicines. So far it yields a good improvement by repigmentation of the lesion. 
Hence I had selected this medicine (Annabedhi Chenduram - externally) as a trial drug in 
my dissertation topic. 
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AIM AND OBJECTIVE 
AIM: 
 The aim of the present clinical study is ―TO EVALUATE THE EFFICACY OF 
THE TRIAL DRUG PARANGIPATTAI CHOORANAM (INTERNAL) AND 
ANNABEDHI CHENDURAM (EXTERNAL) IN THE TREATMENT OF VENPULLI 
(VITILIGO) IN CHILDREN‖. 
 
OBJECTIVES: 
PRIMARY: 
 
To evaluate the efficacy of PARANGIPATTAI CHOORANAM (Internal) and 
ANNABEDHI CHENDURAM (External) in the treatment of VENPULLI (Vitiligo) in 
children. 
 
SECONDARY: 
To study occurrence of new lesion, anywhere else in the body after intake of trial 
medicine.Also, 
 To collect the authorial measures and literature reviews of VENPULLI in ancient 
siddha and modern literatures. 
 Have an idea of the incidence of the disease with regard to age, sex, precipitating 
factors socio economic status, food, kaalam and factors etc. 
 To expose the efficacy of siddhar‘s diagnostic principles. 
 To utilize the modern investigation methods to confirm the diagnosis and prognosis. 
 To study the biochemical and physiochemical analysis of the trial drug. 
  
6 
 
SIDDHA ASPECT 
 
In Siddha system skin diseases are classified under the name kuttam. Generally 
kuttam means ―Group of skin diseases‖. 
 
Venpulli is a chronic skin disease characterized by various sizes of hypopigmentad 
patches in the skin. Synonym of Venpulli is Swetha kuttam. According to Yugi Munivar 
classification Swetha Kuttam is one among the 18 types of Kuttam. 
 
 Description of Kuttam by the Siddhar Dhanvanthiri in his literature ―Dhanvanthiri 
Vaithiyam‖ is given below: 
 
Fl;l Nehapd; G+h;t &gk;: 
 
'njhl;Lg; ghh;j;jhy;  efk;  itj;jhy;  NwhypDzh;r;rp njhpahNj 
nfl;Lr; rhPue;  jbj;jjpw;  fpsWe;  jpdTk; tpuzKkh   
kl;by; tpah;it thpdk; tU khwpA  tUfpD  KyUk;   
tpl;L tpsq;F nkhU td;d NkTq;  Fl;lQ;  rPf;fpuNk"  
 
'epuj;j Tlk;G ruruj;J  neUg;Gg; nghwp gl;lhw; Gz;zha;   
fWj;Nj ,uj;j kaph;f; $r;ry; fhZq; Fzq;fsp Jthfpw;   
nghWj;Nj neLehsD  rhpj;Jg; nghq;Fk; tpahjp nad;wwpf    
kWj;J Kiuj;Njh k`hFl;lk;  tsik  NaOk; GtpkPNj.‖ 
 
 Loss of sensory function e.g., touches, pricking with nail.  
 Erythema or wheal formation all over the body  
 Itching and ulceration  
 Sweating may occur, if occurs it dries up soon.  
 Change in colour of skin  
 Burns like ulcer.  
 Hyperpigmentation 
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ELUCIDATION ABOUT SWETHA KUTTAM: 
    RNtj Fl;lk;  
‗jbg;ghfj; jtsepwk; Nghy; ntSj;Jr; 
  rh;thq;f Kk; ntSj;jhw; whd;wp Uk;Gk;  
kbg;ghf kaph;ntSj;jhy; rhj;a khFk; 
thpthL Ts;sq;iff; Fjq;Fa; ae;jhd; 
nebg;ghf neUg;Gg;gl;lJ Nghw; Gz;zha; 
epwkpUe;jh yrhj;jpa nkd;Nw Aiuf;fyhOk; 
ntbg;ghf Nkdp vy;yhk; ntSj;J tPq;fpy; 
ntz;RNtj Fl;lnkd;Nw tpsk;gyhNk‖ 
 A+fp itj;jpa rpe;jhkzp (Kjy; gjpg;G) 
  ghly; vz;: 514    gf;f vz;: 164 
 
nghUs;: 
RNtjk;     -  ntz;ik> - Whiteness 
tpah;it ghjurk;   
jbg;G     -  fz;bg;G –Strict 
tpiwg;G> filg;G> tPf;fk;  
jtsepwk;     -  rhk;gy; epwk; - Ash Colour Grey 
ntz;ikepwk;> fw;G+uk;  
rh;tk;     -   KOtJk; - Whole/ mq;fk; - ,lk;> gFjp 
ntSj;J     -  ntz;ikahjy;>Growing White 
kbg;ghf    -  nkJthf - Sluggish,NrhW> tise;j 
ntSj;jhw;     -  ntz;ikahjy; - Growing white 
mrhj;jpak;     -  Fzg;gLj;j Kbahik-  Incurability  
thp cjL     -  NfhLNghd;w cjL - Line like lips 
cs;sq;if     - Palm of the  hand 
Fjk;      -  kytha; - anus, Anal Orifice 
Fa;ak;     -  Mz;Fwp / ngz;Fwp -  The genital organ of 
Male / Female 
nebg;ghf     -  neLNeuk;> fhyePl;rp/ 
ePbj;j fhykhd –Chronic 
neUg;Gl;lJ Nghy; Gz;zha; -  jPf;fha jOk;gpd; epwk;>Pinkish white 
ntbg;ghf     -  gpsg;G> ntbj;jy; rpwg;G>Splendours 
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Nkdpnay;yhk;    -   cly;> rh;kk;> - Body 
ntSj;J     -  ntz;ikahjy; - Growing white 
tPq;fpy;     -  nghpjhFjy;> tPf;fk;  kpFjpahf –Abundance 
Reference:  T.V.Sambasivam Pillai Dictionary,  Tamil lexicon 
 
jbg;ghfj; jtsepwk; Nghy; ntSj;J 
 
 fz;bg;ghf rhk;gy; epwk; Nghd;W ntSj;J  
 Strictly the lesion becomes grey white    
 
rh;thq;f Kk;ntSj;jhw; whd;wp Uk;Gk; 
 
 ghjpf;fg;gl;l ,lk; KOtJk; ntz;ikahf khWk; 
 The whole place of the lesion turns to white 
 
kbg;ghf kaph;ntSj;jh yrhj;jpa khFk; 
 
 nkJthf ghjpf;fg;gl;l ,lj;jpy; cs;s kaph; ntz;ikahf khwpdhy; 
Fzg;gLj;jKbahJ 
 Slowly if the hair become grey, it is incurable 
 
thpTjL cs;sq;if Fjq;Fa; ae;jhd; 
 
 NfhL Nghd;w cjL> cs;sq;if> kythia Rw;wpAs;s ,lk;> ,dg;ngUf;f 
cWg;G Mfpaitfspy 
 The Lesion present in lips palms, anus and genital area 
 
nebg;ghf neUg;G gl;lJNghw; Gz;zha;   
epwkpUe;jh yrhj;jpa nkd;Nw Aiuf;fyhFk; 
 
 ePz;l fhykhf> jPf;fha jOk;gpd; epwkhf ,Ue;jhy; Fzg;gLj;j KbahJ  
 Chronically if the lesion present like burns scar color (Pinkish white), It is incurable 
 
ntbg;ghf Nkzpnay;yhk; ntSj;J tPq;fpy; 
 rpwg;ghf ntz;ikahjy; cly; KOtJk; mjpfhpj;J fhzpy 
 The pallor spreads all over the body 
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ntz;RNtj Fl;l nkd;Nw tpsk;ghyNk 
 ntz;ikahd ntz; Fl;lk; vd;W $wyhNk 
 called as Swetha kuttam 
 
AETIOLOGY: 
 
According to siddha system, the predisposing causes for this disease have been 
described as hereditary factor, stress, and strain, malnutrition and venereal exposure and no 
other specific causes have been mentioned for Venpulli. 
 
ACCORDING TO THIRUMOOLAR KARUKKIDAIVAITHIYA NOOL: 
          ―tpahjpAz; %thW tpsq;fpa Fl;lq;Nfs; 
 fahjpf; fpue;jp Rod; Nkfj;jhyhWk; 
 gahjp kz;Zsg; gytz;bdh nyl;Lk; 
 epahjp GOdhyhd; epd;wjpf; Fl;lNk.‖ 
 
 Six types of kuttam i.e skin disease are caused by kirandhi and megham. 
 Eight types are caused by insects in the soil. 
 Four types are caused by worms. 
 
ACCORDING TO YUGHI VAITHIYA CHINTHAMANI 800: 
         “tpsk;gNt kpFe;j c\;ze;jd; dhYk; 
 kpFe;j rPjsj;jhY kow;rp ahYk; 
 tpsk;gNt ke;jj;jhYk; the;jp ahYk; 
 kfj;jhd ngz;NzhL kUtyhYk; 
 fpsk;gNt fpNyrq;fs; kpFjyhYk; 
 nfbahd Twf;fq;fs ilj yhYk; 
 jsk;gNt kapUfw;fs; jtpL kz;fs; 
 rhjj;jpw; gUfyhy; kpFf;Fq; F\;lk;.‖ 
 
The above said literature clearly indicates that the predisposing factors of the diseases are   
 Excessive heat and cold, allergy. 
 Vomiting due to indigestion  
 Hyper sexual indulgence.  
 Mental disturbance  
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 Excessive sleep in day time   
 Frequent intake of food mixed with polluted stone husk and hair  
 
“Fl;le;jhd; gjpndl;L tuNt njd;dpw; 
  FUdpe;ij rptdpe;ij kiuNahu; epe;;ij 
jpl;le;jhd; Njtijiaj; Jh\idf;F Nuhjk; 
  nrg;gyhw; wpUlyhw; gujh uj;ij 
 ml;le;jh dhirahy ilf;f yj;ij 
  mgfupj;j yfjpgu Njrp jd;id 
 tl;le;jhd; itj;jhu; fw;gopj;jy; 
  te;jplNk gjpndl;L Fl;le;jhd;.‖ 
 
 Use of indecent and disrespectful words against god and highly religious and noble 
people. 
 Neglecting phans and beggars 
 Intention to spoil others. 
 Raping 
 Greed 
 Cursing the elders and so on have also been given as predisposing causes by Yughi 
text.  
These habits are supposed to be the factors which lower the immunity of the body ( iyarkai 
vanmai) and make it vulnerable to the disease. 
 
ACCORDING TO AGASTHIYAR KANMA KAANDAM:  
        “Nru;e;Nj Fl;lnkhL FiwNeha;fs; te;j 
  Nrjp Nfs; kyuhj tUk;G nfha;jy; 
 jhupe; rPtnre;J tijfs; nra;jy; 
  jha;je;ij kdJ nehe;J Nuhe; jhNd 
 jhndd;w nja;tU jidaopj;jy; 
  rhu;thd ngupNahu;fs; jikg; gopj;jy; 
 fhndd;w ee;jtdk; G+Q;nrbfs; ntl;ly; 
  fUkklh ruPuj;jpw; fhRNghNy 
 Cndd;w Tlk;ngy;yhk; nghl;L nghl;lh 
  Ald; ntSj;J FiwNehAjpuQ; rpe;Jk; 
 Thndd;w fUkq;fs; jPu;g;gjw;F 
  tifnahd;W nrhy;Ntd;Nfs;.‖ 
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kyuhj mUk;Gnfha;jy;> rPtnre;Jfis tijfs;nra;jy;> ngw;Nwhu; kdij 
NehFk;gb nra;jy; ngupNahu;fs; jk;ik gopj;jy;> ee;jtdk; G+r;nrbfs; ntl;Ljy; 
Mfpa ,f;fhuzq;fshy; Fl;lNeha; tUk; vd;W mfj;jpau; fd;k fhz;lj;jpy; 
$wg;gl;Ls;sJ. 
 
ACCORDING TO PARARASASEKARAM: 
 
 ‗md;dty; tpidap dhNy nkha;j; njOq; Fl;lNuhfk; 
 ikNrh; newpapYa;f;f ew;wtf; Fiuit nka;ik 
kd;dpL kd;gh; jk;ik Ajhrpdk; Ngrp ehSk; 
 ,d;dy; nra; ghj fj;Njhh;f; nfa;jpL nkd;Dk;    
NtjNk Aiuf;F Nkyh newpapdpy; typ ehSk; 
 VjNk GhpAe; jPNahh;f; nfa;Jt ey;yhd; NkNyhh;    
#jpa newpaP dpd;Nw Aaph;fSf; FWjp nra;Ak; 
khjth; ed;iksw;Nwha; tUe;j ehq; fz;bNyhNk    
MdNjhh; thj gpj;j Nrw;gd kjdpdhYk; 
khdha;g; tplePuhY kq;ifah; tUj;jj;jhYk;    
<dkhq; fpue;jpahY kpopTW Fl;lNuhfk; 
jhdkpy; yhNj rhU nkdKdp rhw;wpdhNd    
rhw;wpa Tztpd; Ngje; jd;dhYk; ghy;nea; nty;yk; 
Vw;wkh Az;g jhY kpiwr;rpkP djpfpj; jhYk;    
Nfhw;nwhb klth hpd;gq; Fiwtwj; Ja;f;ifahYk; 
    Nrhw;wpL kyryj;ijr; Rfkw tlf;ifahYk;‖ 
go tpidfs;: 
 Kf;Fw;wkhd thj> gpj;j fgj;jhYk 
 Nfhgk; nfhs;sy; 
 tplePh; 
 ngz;Nghfk; 
 fpue;jp 
 czT Ngjk; 
 ghy;> nea;>nty;yk; mjpfk; cz;gjhYk; 
 ,iwr;rp> kPd; mjpfk; cz;gjhYk; 
 ky ryk; mlf;fyhYk; Fl;lk; cz;lhFk;. 
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CLASSIFICATION: 
ACCORDING TO YUGI VAITHIYA CHINTHAMANI: 
        ― Kj;jhFk; Fl;le;jhd; gjpndl;Lf;Fk; 
   Kdpahd A+fpdhd; nrhy;yf; Nfsha; 
 Gj;jhFk; Gz;luPf F\;lj;NjhL 
  ngUfpd;w tpw;Nghlff; Fl;lkhFk; 
 gj;jhFk; ghkh F\;l Vfru;k F\;lk; 
  gupthd fu;dF\;lk; ru;kF\;lk; 
 fpj;jhFq; fpU\;z Fl;lk; mTJk;gu Fl;lk; 
   Nfbahd kz;ly F\;lkhFk; nkd;nd 
 Fl;lkh kgupr F\;l NkhL 
  kUtyhq; fpBg F\;le; ru;kjy F\;le; 
 jpl;lkhw; jj;JU F\;l NkhL 
  jf;fhd rpj;Jkh F\;lQ; rjhU F\;le; 
 Jl;lkhQ; RNtj F\;ljd; Ndhnlhf;fr; 
  Rak;ghd gjpndl;Lf; Fl;lkhr;Nr.‖ 
 
1. Pundareeka kuttam 
2. Virpodaka kuttam  
3. Baama kuttam  
4. Gaja saruma kuttam  
5. Karna kuttam  
6. Sarma kuttam  
7. Krishna kuttam  
8. Avudhumbara kuttam 
9. Mandala kuttam  
10. Abarisa kuttam  
11. Visarchika kuttam  
12. Vibaathika kuttam  
13.Kideeba kuttam  
14. Sarmathala kuttam  
15. Thethru kuttam  
16. Sithuma kuttam  
17. Sathaaru kuttam  
18. Swetha kuttam (It is also called as Venpadai / Venpulli) 
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ACCORDING TO SIDDHAR ARUVAI MARUTHUVAM: 
Venpadai has been classified into 3 types on the basis of Mukkutram, they are,  
1. Vaatha venpadai   
2. Piththa venpadai  
3. Kaba venpadai  
 
ACCORDING TO SIDDHA SIRAPPU MARUTHUVAM: 
Venpulli has been classified into 4 types:  
1. Vaatha venpadai   
2. Piththa venpadai  
3. Kabha venpadai  
4. Mega venpadai  
 
ACCORDING TO ATHMA RAKSHAMIRTHA VAIDHYA SARASANKIRAHAM: 
Venpadai is classified into 4 types  
1. Venkuttam  
2. Senkuttam  
3. Karunkuttam  
4. Peru viyathi  
 
CLINICAL FEATURES OF KUTTA ROGAM: 
ACCORDING TO THANVANTHIRI VAITHIYAM: 
 ―kPf;nfsj; NjhW}nkYNkhu; Kfk; ntSf;Fkhfpy; 
  Nehf;fpay; kupf;FQ; nrhd;d ntz;Fl;lkhNk.‖ 
 
ACCORDING TO VAITHIYA SAARASANGIRAHAM: 
 
 Venpulli is a disease characterised by white coloured patches which are 
circumscribed along with thickened border in sole, hands,lips,scalp,fingers and wrist 
joint. 
 Blood, Muscles, and adipose tissue are also affected by this disease.  
 Discolouration of hairs,absence of normal skin texture comparing the adjoining 
normal skin area and appearance of burns are indicates noncurable nature of disease. 
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ACCORDING TO ANUBHAVA VAITHIYA DEVA RAGASIYAM: 
 
 ,e;Nehia F\;lnkd $wpDk; ,J F\;l tiffspd;W NtWgl;lJ 
vd;gijAk; F\;lj;ijg;Nghy; mt;tsT nfhLikahd tpahjp my;yntd;Wk; 
czuNtz;Lk;. ,e;Nehapy; jpl;Ljpl;lhf ntz;ik epwkhd gilfs; cz;lhfp gpwF 
Njfk; KOtJk; gutp cliy tpfhug;gLj;Jjy; Kjypa Fzq;fis cilaJ. 
 
ACCORDING TO SIRAPPU MARUTHUVAM: 
1. Vaatha venpadai  
2. Piththa venpadai   
3. Kaba venpadai  
4. Mega venpadai 
 
1.VAATHA VENPADAI: 
It is characterized by the depigmented patches, which are dry, rough,reddish with 
somewhat pale black in colour. 
 
2. PITHTHA VENPADAI: 
It is characterized by the depigmented patches red in colour like lotus flower, 
spreading with burning sensation and loss of hairs on that area. 
 
3. KABA VENPADAI: 
Itis characterized by the depigmented patches white in colour like leucus flower 
spreads with rashes and itching. 
 
4. MEGA VENPADAI: 
It is due to the venereal disease syphilis and it occurs after 4 or 6 months after the 
onset of disease. It develops initially along the nape and the adjoining spaces.Also gradually 
it affects the shoulder joints; back of trunk. It is clinically characterized by hypopigmented 
patches with hyperpigmented margin which are few in number. They are pale, turmeric and 
dark in colour.These lesions are circumscribed with 2mm to 3mm diameter or above. The 
nature of hypopigmented and hyper pigmented skin resembles the appearance of sieve. 
Females are more prone to this mega venpadai, therefore anti-syphilitic therapy is 
mandatory in the early period of the treatment. 
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CHARACTER OF VENPULLI: 
1. The imbalance of the three thadhus produces certain lesions in skin known as 
kuttam.  
2. Skin colour will change to reddish black or reddish white or white colour with 
spreading nature.  
3. Absence of perspiration and thickening of skin may produce the colour changes in 
skin. 
 
jPUk;> jPuhjit: 
 
rhj;jpak; - 11: 
 ―G+z;le; EutpNdhL rjhupfk; Gz;luP fe;j 
  jhz;L tpw;Nghlk; ghkhTld; ikjyk; ntq;Fl;lk; 
  $z;bL fhfwe;jp rpWik ary Fl;lk; 
  Ntz;La tpahjpNahLk; gjpndhd;W}k; tpupj;Jf; fhNd.‖ 
 
mrhj;jpak; - 7: 
 ―nrhy;YFl;lk; vOtifNgu; nrhy;ypf; fghy ru;kPfk; 
  nty;Y KJk;gh Nkfpbgk; tpru;r;rpkz;lyf; fpuKk; 
 ky;yy; jUkPrp aFit ahFk; ngaNuh NuohFk; 
  ty;yfpahjpf; Fzkjid tFj;Jg; ghupYW}iug;Ngd;.‖ 
 
CURABLE-11: 
1. Thethuru kuttam  
2. Sadhaaru kuttam   
3. Pundareega kuttam   
4. Virpodaga kuttam 
5. Sarmathala kuttam   
6. Baama kuttam   
7. Kaha nandhi kuttam 
8. Venkuttam  
9. Sithuma kuttam  
10. Alasa kuttam  
11. Vibaathiga kuttam  
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INCURABLE -7: 
1.Kabaala kuttam  
2. Sarumamega kuttam   
3. Kideeba kuttam   
4. Avudhumbara kuttam   
5. Visarchika kuttam  
6. Aguvai kuttam   
7. Mandala kuttam 
 
IN YUGI CHINTHAMANI-800: 
 ―Fl;le;jid gjpndl;by; rhj;jpae;jhd; 
    $wf;Nfs; tpw;Nghlf ghkh Fl;lk; 
 jpl;le;jhd; nfrru;k Fl;lnkhL 
  fpUl;bz Fl;lkTJk;gu Fl;le;jhDk; 
 jpl;lkhe; NjjpjpUf; Fl;lnkhL 
  nra;rpj;Jkh Fl;lq; fpbg Fl;lk; 
 jl;le;jhd; kpFe;j rjhU Fl;lk; 
  rkfpUl;z Fl;lk; rhj;jpakh nkd;nd.‖ 
 
CURABLE -10: 
1.Virpodaga kuttam  
2. Baama kuttam  
3. Gaja saruma kuttam  
4. Krishna kuttam   
5. Avuthumbara  kuttam 
6. Thethuru kuttam  
7. Sithuma kuttam  
8. Kideepa kuttam  
9. Sathaaru kuttam  
10. Sarmathala kuttam  
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INCURABLE -8: 
1. Pundareeka kuttam  
2. Karna kuttam  
3. Sikura kuttam  
4. Mandala kuttam  
5. Abarisa kuttam  
6. Visarchika kuttam  
7. Swetha kuttam  
8. Vivadhika kuttam  
 
MUKKUTRA VAERUPADUGAL (PATHOGENESIS):   
Disease occurs due to the derangement in 
 Uyir thathukka 
 Udal thathukkal 
 Kalamarupadu (seasonal changes) 
 Thinai (living lands) 
 Udal vanmai 
 
MUKKUTRA IYAL:   
The function of the three uyir thathus 
a) Vali – Kattru + Veli  
b) Azhal – Thee   
c) Iyyam – Neer + Mann  
 
The alteration of three thathu in their reaction to extrinsic or intrinsic factors results 
in disharmony. This altered harmony and balance variation of the three results in disease. 
Their natural ratio (1:1/2:1/4) to each other is discerned by the physician at the wrist and 
each nadi is individually assessed for its strength, speed and regularity. 
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VATHAM: 
The term vatham denotes vayu, dryness, pain and flatulence. Based on functions and 
locations it is classified into ten types. They are tabulated below. 
 
S.No Vatham General Features 
Changes in 
Venpulli 
1 Piranan 
(Uyirkkaal) 
Responsible for respiration and it is 
necessary for proper digestion. 
Normal 
2 Abanan (Keel 
nokkukkaal) 
Responsible for all the downward forces 
such as voiding of urine, stools, semen, 
menstrual flow. 
Normal 
3 Viyanan 
(Paravukaal) 
Dwells in the skin and is concerned with 
the sense of touch, extension and flexion 
of the parts of the body and distribution 
of the nutrients to various parts of the 
body. 
Affected (skin 
colour changed into 
white) 
4 Uthanan  
(Melnokkukaal) 
Responsible for all kinds of upward 
motion such as nausea, vomiting etc., 
Normal 
5 Samanan 
(Nadukkaal) 
Start from the umblicial cord, Samanan 
spread out upto the lower limbs and 
responsible for the balance of other four 
vadha and digestion. 
Affected ( It cannot 
control the other 
vayus) 
6 Nagan Helps in opening and closing of eyelids. Normal 
7 Koorman Responsible for vision, lacrimation and 
yawning. 
Normal 
8 Kirugaran Induces appetite, salivation, all secretions 
in the body including nasal secretion and 
sneezing. 
Normal 
9 Thevathaththan Induces and stimulates a person to 
become alert, get anger, to quarrel, to 
sleep etc., 
Normal 
10 Dhananjeyan Resides in the cranium and produces 
bloating of the body after death. This 
leaves from the body after 3 days of 
death, forming a way through the skull. 
Normal 
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PITHAM: 
It is the thermal life force of the body. It is sub divided into five types. They are  
 
S.No Pitham General Features 
Changes in 
Venpulli 
1 Anarpitham Peps up the appetite and aids in 
digestion. 
Normal 
2 Ranjagapitham Responsible for the colour and contents 
of blood. 
Affected 
3 Saathagapitham Controls the whole body and is held 
responsible for fulfilling a purpose. 
Normal 
4 Pirasagapitham Dwells in the skin and concerned with 
the shine, glow, texture and its 
complexion.  
Affected (skin 
colour Changed 
into white) 
5 Alosagapitham Responsible for the perception of vision. Normal 
 
KABHAM: 
It is responsible for the stream line functions of the body and maintains body‘s defence 
mechanism intact. It is again classified into 5 types. 
 
S.No Kabham General Features 
Changes in 
venpulli 
1 Avalambagam Lies in the respiratory organs, exercises 
authority over other kabhas and control 
the heart and circulatory system. 
Normal 
2 Kilethagam Found in stomach as it seat, moistens the 
food, softens and helps to be digested. 
Normal 
3 Pothagam Responsible for the perception of taste Normal 
4 Tharpagam Presents in the head and is responsible 
for the coolness of the eyes, sometimes 
may be referred to as cerebrospinal fluid. 
Normal 
5 Santhigam Necessary for the lubrication and the free 
movements of joints. 
Normal 
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PARUVAKALAM:  
 
S.No Perum pozhuthugal Mukkutra marupaadugal 
1 Kaar kaalam 
(Aavani & Purattasi) 
Mid-August to Mid-October 
VATHAM - Vaetrunilai valarchi 
PITHAM – Thannilai valarchi 
 
2 Koothir kaalam 
(Iypasi & Karthigai)  
Mid-October to Mid-December 
VATHAM – Thannilai adaidhal 
PITHAM - Vaetrunilai valarchi 
3 Munpani kaalam 
(Margazhi & Thai)  
Mid-December to Mid-February 
PITHAM – Thannilai adaidhal 
4 Pinpani kaalam 
(Masi & Panguni) 
Mid-February to Mid-June 
KABHAM – Thannilai valarchi 
5 Elavenir kaalam  
(Chithirai & Vaikaasi)  
Mid-April to Mid-June 
KABHAM – Vaetrunilai valarchi 
 
6 Mudhuvenir kaalam  
(Aani & Aadi)  
Mid-June to Mid-August   
VATHAM– Thannilai valarchi 
KABHAM – Thannilai adaidhal 
 
THINAI (LAND): 
 Siddhars classified the lands into five types. They are   
1. Kurunji  –  Mountain range  
2. Mullai  –  Pastoral area of the forest   
3. Marudham  –  The fertile river bed   
4. Neidhal  –  The coastal region  
5. Paalai –  Arid desert  
 
 Kabha diseases will occur in Kurinji land. Pitha diseases occur in Mullai land. 
Vadha diseases occur in Neidhal land. Staying in Paalai land is not good to health. 
Marudham land is the fertile area where no disease occurs. So, Marudham land is 
the best one to stay in. 
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 The winter season gives good health to the man, early summer and later rainy gives 
moderate health. Whereas early rainy and later summer are more prone to diseases, 
that‘s why siddhars called it as Aanaga kaalam. 
 
RELATION BETWEEN MUKKUTRAM, KAALANGAL AND THINAIGAL: 
 
Mukkutram 
Paruvakaalam (Seasons) 
Thinai Thannilai 
valarchi 
(Accumulation) 
Vaetrunilai 
valarchi 
(Aggravation) 
Thannilai 
adaidhal 
(Alleviation) 
VATHAM 
Mudhuvenil 
kaalam 
Kaar kaalam Koothir kaalam 
Vatha disease is 
more prevalent in 
Neidhal land. 
PITHAM Kaar kaalam Koothir kaalam 
Munpani 
kaalam 
Pitha disease is 
more prevalent in 
Mullai land 
KABHAM Pinpani kaalam Elavenil kaalam 
Mudhuvenil 
kaalam 
Kabha disease is 
more prevalent in 
Kurunji land 
 
UDAL VANMAI (IMMUNITY): 
Siddhars classify udal vanmai into three types. They are  
1. Iyarkai vanmai  
2. Kala vanmai  
3. Seyarkai vanmai. 
 
UDAL KATTUGAL: 
S.No Udal kattugal General Features 
Changes in 
Venpulli 
1 
Saaram  (Digestive 
essence) 
Responsible for the growth and 
development. It keeps the individual in good 
temperament and it enriches the body. 
Affected 
2 Senneer (Blood) 
Responsible for the color of the blood and 
for the intellect, nourishment, strength of the 
body. 
Affected 
3 Oon (Muscle) 
Gives lookable contour to the body as 
needed for the physical activity. It feed the 
fat next day and gives a sort of plumpness to 
the body. 
Normal 
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4 Kozhuppu (Fat) 
Lubricates the organs to facilitate 
frictionless functions. 
Normal 
5 Enbu (Bones) 
Supports and protects the vital organs, gives 
the definite structure of the body and 
responsible for the posture and movements 
of the body. 
Normal 
6 
Moolai (Bone 
marrow) 
Nourishes the bone marrow and brain which 
is the centre that controls other system of 
body. 
Normal 
7 
Sukkilam/Suronitham 
(Sperm/Ova) 
Responsible for reproduction Normal 
 
PINIYARI MURAIMAI (DIAGNOSIS): 
Four steps are followed in diagnosing the disease. They are  
1. Poriyaal aridhal  
2. Pulanal therdhal  
3. Vinaadhal  
4. Envagai thervugal 
 
PORIYAAL ARIDHAL: 
In this, the physician should carefully observe the changes that occur in the five 
sensory organs (porigal) of the patient.  
 
PULANAL THERDHAL:   
The physician carefully applies his five senses of perception, smell, taste, vision, 
touch and sound to understand the condition of the patient.  
 
VINAADHAL: 
 The physician should interrogate about the patients name, age, occupation, socio- 
economic status, food habits, history of past illness, history of present illness, family history 
and frequency of pain.  
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ENVAGAI THERVUGAL:  
 “ ehbg;guprk; ehepwk; nkhoptpop 
 kyk; %j;jpukpit kUj;JtuhAjk;‖ 
 
Nowadays advanced diagnostic tools have been developed by modern bio medical 
scientists. But siddhars have given eight diagnostic methodological tools. They are called as 
Envagai thervu.  
 
Eight fold system of clinical assessments:   
Siddhars have given eight diagnostic methodological tools. They are  
1. Naadi  
2. Sparisam  
3. Naa  
4. Niram  
5. Mozhi  
6. Vizhi 
7. Malam  
8. Moothiram 
 
GENERAL FINDINGS:  
NAADI:   
 
Naadi is responsible for the existence of life, can be felt one inch below the wrist on 
the radial side by means of palpation with tips of index, middle and ring finger, 
corresponding to vatham, pitham, kabham. 
 
Three humours Vatham, Pitham, and Kabham are in the ratio 1:1/2:1/4 normally. 
Derangement in these ratio leads to various disease conditions.  
Naadi nadai in Venpulli, 
Vathapitham or Pithakabam. 
 
SPARISAM:   
By sparisam, the temperature of skin (thatpam- cold or veppam – heat), smoothness, 
roughness, sweating, dryness, hard patches, swelling, abnormal growth of organs and 
tenderness can be felt. 
In Venpulli – Affected area may be or may not loss of sensation. 
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NAA:   
Signs and symptoms in the tongue are noted here. Colour, salivary secretion, ulcers, 
coating, inflammation, taste changes, deviation and its nature are generally noted. 
 
In Venpulli – In anaemic condition tongue may be Pallor.  
 
 
NIRAM: 
The colour of the skin is noted here. 
In  Venpulli – The natural colour becomes pale or diminished. 
 
 
MOZHI:  
Character of the speech is noted, mainly uraththa oli (high pitched), thazhndha oli 
(low pitched), or resembles the sound of any instrument. 
In Venpulli – No changes in voice. 
 
 
VIZHI:   
Character of the eye is noted. Colour, warm, burning sensation, irritation, visual 
perception are generally noted.  
In Venpulli- Not affected.  
 
 
MALAM: 
The stools are examined for quantity, hardening (malakattu), loose motion (bedhi), 
colour and smell. 
In Venpulli – Normal   
 
 
MOOTHIRAM: 
a) NEERKURI (Urine examination): 
Urine examination is good diagnostic method compared to naadi and other Envagai 
thervugal. Theraiyar mention it as. 
―mUe;Jkh wpujKk; mtpNuhjkjha; 
mf;fy; myu;jy; mfhyt+z; jtpu;j;jow; 
 Fw;wstUe;jp cwq;fp itfiw 
  Mbfyrj; jhtpNa fhJnga; 
njhUK$u;j;jf; fiyf;Fl;gL ePupd; 
epwFwp nea;Fwp epUkpj;jy; flNd.‖ 
The early morning urine sample is collected and sample should be examined within 
90 minutes. 
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SIRUNEERIN POTHU GUNAM:  
―te;j ePu;fup vil kzk; Eiu vQ;rnyd 
iwe;jpaYsit aiwFJ KiwNa.‖ 
 
The urine is examined for its Niram (colour), Eadai (Specific gravity), Nurai (Froth), 
Natram (Smell), Enjal (Deposits). 
 
NIRAM (COLOUR) NIRA THOGAI  
 ― gPjk; nrk;ikigq; fUik ntz;iknad; 
  Nwhijaq; nfhOikia nahj;JF ePNu.‖ 
1. Yellow  
2. Red  
3. Green  
4. Black  
5. White. 
Urine may be any colour as mentioned above. 
 
EADAI (SPECIFIC GRAVITY): 
Urine, not thick is considerably healthy. This is mentioned as 
 ―kpf jbg;Gk; kpfj; NjwYk; ,d;Nwdpy; 
  Rfj;ijj; jUk; nka;r; Rght ePu; ed;Nw.‖ 
 
NURAI (FROTH): 
Urine may be frothy in nature, if it is reduced, vali, azhal and ayyam are said to be 
deranged. This is mentioned as  
 ―ge;jnka;g; girapsfgLk; gUtj; 
 je;ju;g; G+jkha; mdpy %j;jpuj;jpy; 
 rk;ge;jgLk; jjpDiug; GdNy.‖ 
 
NEIKURI: 
The early morning urine of the patient is analysed by dropping a drop of gingelly oil 
on the surface of the urine sample. The accumulation, formations, changes, and dispersal 
under the sunlight without any external disturbances of the urine sample can be noted. The 
urine kept on the kidney tray in sun light, on non-wind condition, should be examined by 
dropping a drop of gingelly oil. If oil spread like snake, it indicates vali neer; a ring 
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indicates azhal neer and float like a pearl indicates iyya neer and sinks in urine indicates 
mukkutram. 
  ―muntd ePz;bd/Nj thjk; 
 Mop Nghw; gutpd; m/Nj gpj;jk; 
 Kj;njhj;J epw;fpd; nkhoptnjd; fgNk.‖ 
 
 Vatha neer – The oil spreads like snake 
 Pitha neer – The oil spreads like ring 
 Kabha neer – The oil spreads like pearl 
 If the oil spreads gradually, it indicates good prognosis 
 If the oil spreads fast or gets mixed completely with urine or sinks in urine, it 
suggests bad prognosis  
 
MANAGEMENT OF VENPULLI: 
REJUVENATION:  
KALPA MARUNTHU: 
 
Pothu kalpam, Ponnangaani karpam (Alternanthera sessilis)(Used as recipes along 
with milagu (Piper nigvum),kariuppu(Sodium chloride). 
 
SIRAPPU:  
 KITTIKIZHANGU (Acalypha fruticosa) used as daily dishes like curry, vatral,etc.., 
Lemon used as pickle or juices (To be continued for six months). 
 Ayapirungaraja karpam 
 Ayajambeera karpam 
 
KALPA YOGAM: 
 
 Sarvangaasana is most useful for this complained shirasana is also useful, whereas 
the other asanam have been included for general health and fitness. 
 Pranayamam 
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THE COMMON BENEFITS OF YOGAM: 
SARVANGASANAM USES: 
It prevents narai, thirai and moopu (i.e) prevents ageing .By stimulating the thyroid gland it 
gives strength to all the organs of the body .It cures kutta noi. 
 
UNAVU: 
TO BE ADDED:   
 Drink adequate water   Green vegetables/spinach 
 Carrot     Watermelon 
 Coriander    Beetroot 
 Soya beans    Walnuts 
 Pumpkin    Apple 
 Fig fruit    Honey 
 Banana flower    Pomegranate 
 Black dates 
 
TO BE AVOIDED:   
 Bitter gourd                              Brinjal 
 Sea foods                      Pickles 
 Chicken     Papaya 
 Chocolate                                 Green chilli 
 Tamarind     Citrus fruits (Grapes, Orange, Lemon) 
 Packaged food         Tinned foods or drinks 
 Curd     Raw tomato     
 Coffee     Raw garlic 
 Raw onion         
 
OTHER ADVICES:  
 OLEATION: Oil bath should be taken twice a week which is advisable. 
 It is better to add bitter tasted herbs like azadirachta indica, acacia catechu etc..,  
 Eechaam paai a type of mattress prepared from the leaves of phoenix sylvestris. 
 Food stuff that bring the vaatha ,piththa and kabha dhoshas to the normal physiology 
level have to  be consumed.  
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MODERN ASPECTS 
 
THE SKIN: 
Dermatology is the study of skin diseases. Disease of the skin, are a common 
occurrence, account for a great deal of misery, suffering in capacity and economic loss. A 
very few skin diseases are contagious. 
 
Hippocrates, Father of Medicine described many skin diseases and divided them into 
two groups according to their exogenous or endogenous causes. He attributed the origin of 
disease to abnormal mixing of black and yellow bile, blood and phlegm. The theory of 
abnormally mixed humors played a major role in dermatology for a long time. 
 
Dermatology is a branch of medicine dealing with the skin. Its roots reach back to 
antiquity. The obviously manifested skin diseases have drawn the attention of men since 
time immemorial.  
 
SKIN ANATOMY 
The human skin is the outer covering of the body and is continuous with the mucous 
membranes in the region of the mouth, nose, urogenital organs and the anus. In an adult the 
skin surface measures 1.5 - 2 m while the thickness of the skin varies from fractions of a 
millimetre to 4 mm. The thickness of the epidermis varies from 0/06 - 0.9 mm to 0.5 - 0.6 
mm. The thickness of the subcutaneous fat varies considerably. Some areas are devoid of fat 
while in others (on the abdomen and gluteal regions), it is several centimetres thick. The 
mass of skin of an adult accounts for approximately 5 % while together with subcutaneous 
fat for about 10 to 17.7 % of the total body mass.  
  
NORMAL SKIN STRUCTURE: 
 The colour of the skin may change because the amount of the pigment in it varies 
due to external and internal factors. The skin surface is covered with hairs over a great area. 
The areas devoid of hairs are the lips, palms and soles, glans penis, inner surface of the 
prepuce and the inner surface of the labia majorum and minorum. 
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Figure 1 : Structure of skin 
 
SKIN HISTOLOGY: 
 
The skin develops from two germinative zones. The ectoderm which is represented 
by the epidermis (the most superficial skin layer) and the mesoderm (the middle embryonal 
layer) represented by two layers namely the true skin, or dermis (the middle layer) and the 
subcutaneous fat or hypoderm the deepest skin layer. 
 
The boundary between the epidermis and dermis forms a wavy line because of the 
presence of skin papilla (special out growth on the surface of the true skin) the spaces 
between which are filled with epithelial processes. 
 
VASCULAR SYSTEM OF SKIN: 
Vascular system of the skin is formed of several networks of blood vessels. Large 
arterial vessels stretch from the bascia through the subcutaneous fat and give off small 
branches to the fat lobules. On the boundary of the dermis and hypoderm, they divide into 
branches which stretch horizontally and anastomose with one another. A deep arterial 
plexus of skinforms, which gives rise to branches supplying the holes of the sweat glands, 
the hair follicles and the fat lobules. The epidermis is devoid of blood vessels. The most 
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powerful network of blood vessels is located in the skin of the face, palms, soles, lips, 
genitals and in the skin around the anus.                                                             
LYMPHATIC SYSTEM OF SKIN: 
The lymphatic system of the skin forms superficial and deep networks. The 
superficial lymphatic network arises on the papillary layer as blind rounded dilated 
capillaries between which there are numerous anastomoses. The second network of lymph 
vessels is in the lower part of the dermis and already has valves. There is a network of 
wide loops forming lymphatic plexus and deeper parts are continuous with lymph trunks 
LAYERS OF THE SKIN: 
EPIDERMIS: 
 
The epidermis is stratified epithelium undergoing keratinization; it consists of the 
following layers: 
i)  Germinative layer of stratum basale 
ii) Prickle - cell layer or stratum spinosum 
iii) Granular layer or stratum granulosum 
iv)Stratum lucidum 
v) Horny layer or stratum corneum 
There are many nerve endings in the epidermis but no blood vessels and the cells 
are supplied with nutrients by the lymph flowing in the intercellular slits. 
 
DERMIS: 
The dermis is located between the epidermis and the subcutaneous fat. Two layers 
are distinguished in it, the papillary or subepithelial layers and the reticular layer. The 
papillary layer is that part of the dermis which is found between the epidermis and the 
superficial network of blood vessels. The reticular layer merges with the subcutaneous fat 
and is not demarcated from it sharply.The dermis is supportive connective tissue, mainly 
collagen, elastin and glycosaminoglycan.  
 
SUBCUTANEOUS LAYER:   
The subcutis consists of loose connective tissue and fat (upto 3 cm thick on the 
abdomen). 
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BLOOD AND LYMPHATIC VESSELS:  
The skin also has a rich and adaptive bloodsupply. Arteries in the subcuits 
branchupwards, forming a superficial plexus at the papillary/ reticular dermal boundary. 
Branches extend to the dermal papillae .each of which has a single loop of capillary 
vessels, one arterial and one venous, Veins drain from the venous side of the loop to form 
the mid dermal and subcutaneous venous networks. In the reticular and papillary dermis 
there are arteriovenous anastomoses which are well innervated and concerned with 
thermoregulation.  
The lymphatic drainage of the skin is important, and abundant meshes of 
lymphatics originate in the papillae and assemble into larger vessels which ultimately drain 
into the regional lymph nodes.   
 
PIGMENTATION OF THE SKIN: 
The colour of the skin may be brown or even black according tothe amount of 
pigment present and it varies due to external and internal factors.Even in white races most 
parts of the skin contain brown pigment granules in the deepest layer of the germinative 
zone of the epidermis. In dark races they are more abundant and extend throughout the 
whole zone.The degree of racial pigmentation does not depend on the number of 
melanocytes present but on their metabolic activity and the size and shape of their melanin 
producing organelles the melanosomes.   
 
Brownness of the skin depends upon the transfer of melanosomes from 
melanocytes into keratinocytes.Melanosomes are cytoplasmic particle formed in 
melanocytes and then distributed among the basal cells of the epidermis.Each melanocytes 
in the epidermis secrete melanosomes are site of melanin synthesis by the action of 
tyrosinase upon tyrosine. 
 
MELANIN: 
Melanin - Derived from the Greek word Melas, meaning black. 
Melanin is endogenous nonhaemoglobin derived brown or black pigment formed 
when the enzyme tyrosinase catalyses the oxidation of tyrosin to dihydroxy phenylalanine 
(DOPA) in melancocytes. 
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DISTRIBUTION: 
It is widely distributed in the body but peculiarly enough it is limited only to those 
structures which have got an ectodermal origin, for eg: skin, hair, choroid coat of retina and 
substantia nigra of the brain. It is formed from tyrosine by oxidation, metabolism and 
polymerization. 
 
FUNCTIONS: 
The function of melanin in the choroids is namely to convert the eye ball into a 
perfect dark chamber. Since nervous tissue is derived from ectoderm, the melanin in the 
substantia nigra may represent the vestigial remnants of the melanin in the substantia nigra 
may represent the vestigial remnants of the melanin forming properties. Melanin is the great 
protector of the skin against the actinic rays of the sun. 
 
MELANIN FORMATION: 
Melanin, wherever it is found, is formed in the local cells by the enzyme tyrosinase 
(or) melanase. The mother substance, upon which the enzyme acts, is a tyrosine derivative 
(DOPA) believed to be formed in the adrenals.  
 
Melanin formation in both human and amphibian skin is augmented by the harmone 
known as intermedian or melanocyte - stimulating harmone (MSH) secreted by the pars 
intermedia of the pituitary gland. Adrenocartico tropic harmone (ACTH) secreted by 
Anterior Pituitary has melanocyte - stimulating activity similar to MSH although to a much 
lower degree. In Addison‘s disease ACTH is secreted in a large amount and there is 
brownish black pigmentation of the exposed parts of the skin eg. hands, feet and mucous 
membrane. 
 
Melatonin extract from bovine pineal gland, causes concentration of melanin near the 
nuclei of melanocytes in frog and as a result of this the skin becomes pale. Its role in the 
human is not known. MSH causes the serum copper to rise and this is accompanied by in 
the melanin formation. Diminished formation of melanin is seen in albinism and 
leucoderms. In melanocytic sarcoma, melanin may be found in the urine. 
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TYPES OF PIGMENTARY DISORDER: 
 
Excessive pigmentation is known as hyper pigmentation and decreased pigmentation 
is known as hypo pigmentation. Both may be localized or generalized. In addition, 
increased pigmentation may result from deposits of abnormal non melanin pigments in the 
skin, E.g: Haemosiderin from broken down haem pigment in extravasated blood.  
 
Homogentisic acid deposited in cartilage particular in the inherited metabolic defect 
known as alkaptonuria.Drugs and heavy metals toxicity. Silver, Gold, Mercury, Arsenic 
poisoning, Amiodarone and phenothiazine causes slate grey, dusky skin pigmentation in 
exposed sites. 
 
VITILIGO: 
 
The name ‗vitiligo‘ is derived from the Latin word skin eruption, victim meaning a 
blemish (spoil the beauty of) happens to be a synonym for it.White skin is the literal 
meaning of leucoderma, derma being derived from the Greek words, leucas and dermis. 
Leucas means white and dermis means skin.Celeus was the first Roman physician of the 
2nd century to coin the word vitilligo, because the disease resembles the white patches of a 
spotted calf (vitelus). 
 
Vitiligo is characterized by the presence of non-pigmented areas of irregular shape, 
which develop on the epidermis of skin and hair. In this condition there is absence of 
deficiency of melanin, a dark pigment of the skin produced by melancytes under the 
stimulation of the sun light and possibly, under the control of a melanin stimulating 
hormone of the hypophysis.It is also regarded to develop through eczema scar of prick by 
injection needle, injury by burn or from other accidents, by friction of foot, wearing tight 
clothes. It has also been observed in persons who have suffered serious illness due to 
typhoid, jaundice, liver diseases, diabetes, worms, constipation and diarrhoea. 
 
The non-pigmented patches whitish or reddish are round or oval in shape with 
smooth surface and slowly grow into large, irregularly outlined areas. It may be the result 
of skin diseases or it may be a harmless condition of unknown cause. 
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DEFINITION: 
Vitiligo is a disorder of the skin especially due to loss of pigment without any 
disturbances and textural alterations.A condition due to failure of melanin formation in the 
skin produces sharply demarcated, milky white patches with hyperpigmented borders. 
It is an extremely common depigmentary disorder of great medico social 
significance among the dark people, aetiology is uncertain association with variable 
penetrance; no age is except, both sexes. A symptomatic puncture linear, oval, circular or 
irregular, discrete or confluent depigmented and or hypopigmented macules on otherwise 
normal skin is confined to mucocutaneous functions dermatomal unilateral or bilateral, 
symmetrical or asymmetrical generalized or universal over laying hair retain pigment or 
turn white, no autonomic or sensory disturbances, sub burn or chronic solar damage in 
longstanding cases, unpredictable and capricious course, stationary, self-healing or 
progressive. 
It is quite clear that vitiligo is due to some derangement in the pigment metabolism 
resulting in appearance of white patches in the skin. It is hard to say whether the site of 
derangement is usually general or local, but the main affected part is the skin, which is the 
most exposed part of the body. It can be examined by naked eye and can furnish a lot of 
information about the person and the disease. In certain cases the changes are not clear. 
Hence the study of the skin structure and its physiology is essential for proper assessment. 
 
EPIDEMIOLOGY: 
 
Vitiligo is an acquired idiopathic depigmentary condition which, though worldwide 
in distribution, is most common in India, Egypt and other tropical countries. It is a source 
of great social embarrassment of dark-skinned people. It affects all age groups with no 
predilection to either sex. 
 
GROSS ANATOMICAL CHANGES IN VITILIGO: 
 
Vitiligo represents an acquired patchy loss of pigments of the skin. There are no 
gross changes seen except irregularly demarcated, depigmented patches of varying size, 
usually surrounded by hyperpigmented skin. These are seen distributed symmetrically or 
asymmetrically at various parts of the body. 
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HISTOPATHALOGIC CHANGES IN VITILIGO: 
 
Marked histological changes do not occur in cases of vitiligo. All the layers of the 
epidermis and dermisappear normal except a few changes which can be seen after special 
stains. 
 
In the affected area the basal cells and the keratinizing cells of the other layers of 
epidermis do not contain melanin pigment granules in them. The contrast can be seen at a 
junction of the normal and vitiliginous areas of the skin, especially by silver staining or 
DOPA reaction. The pigment cells, the melanocytes are not seen in the affected area but 
they are present in the adjacent normal skin. At the border of the patches of vitiligo  the 
melanocytes often appear large and possess long dendritic process filled with melanin 
granules. Electron microscopic studies confirm the absence of melanocytes in areas of 
long standing vitiligo. 
There are collections of mononuclear cells at dermo epidermal junction at the 
border between vitiliginous and normal skin. These cells are predominately small 
lymphocytes. In the long standing cases where the skin has become thick and scaly, 
varying amount of the keratosis is seen.  
 
POSSIBLE CELLULAR AND HUMORAL IMMUNE MECHANISMS OF 
VITILIGO 
Fig 2: 
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ETIOLOGY – VITILIGO: 
 
 Melanocytes in areas of depigmented skin are destroyed and the cause is unknown. 
Anti-melanocytic anti-bodies directed against intra cellular components of 
melanocytes have been shown. The presence of organ specific auto immune disease 
occurs in about 10 % of patients. Such conditions are more common in their families 
than in a normal population. A neurogenic defect has been postulated for the rare 
dermatomal pattern of vitiligo which affects principally the limbs. 
 Endocrines - Association with thyrotoxicosis and diabetes. 
 Trophoneurosis and autonomic imbalance - emotional stress and strain. 
 Infections and toxic products, Enteric fever ill health, focal sepsis. 
 Drugs and chemicals - like quinines, guano furacin, amylphenol, chlorthiazide, 
broad spectrum antibiotics and chloroquin. 
 Auto-immune thyroid disease is one of a group of organ specific auto immune 
diseases that include pernicious anaemia, Addison‘s disease and hypo para - 
thyroidism. 
 
HEREDITARY FACTORS: 
Hereditary is one of the factors supposed to be related with this disease to some 
extent. Familal incidence has been reported in 7.5 to 21 % in India and 33 to 40 % in 
western countries. 
 
EMOTIONAL FACTORS: 
It is every day knowledge and observation that emotional factors affect the skin as 
shown by the blushing of embracement, the pallor of fear and the pallor or redness of 
Change, depending on the subject and his emotional state. Experiments have demonstrated 
that emotional change can affect the following, which has direct relevance in the aetiology 
of certain skin disorders. 
• Control of vascularity of the skin 
• Control of sebaceous gland secretion. 
• Influencing the degree of oxidation. 
• Influencing the tendency of pruritus. 
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III PATHOLOGY: 
Chemically melanin pigment is a group of chromo proteins with colored prosthetic 
groups, which is derived from the precursor tyrosine in the following way Tyrosine, 
Tyrinase Dihydroxy phenylanin (DOPA), Melanogenase, Melanin (Dopa oxidase). 
Melanin + Protein = Melano protein. 
 
THE POSSIBLE PATHOGENETIC MECHANISM: A SCHEMATIC PICTURE OF 
THE CAUSAL AND TEMPORAL SEQUENCE LEADING TO THE 
MELANOCYTE FUNCTIONAL IMPAIRMENT DURING VITILIGO 
Fig 3: 
 
 
In the skin, the pigment is produced by the melanocytes from their precursor‘s 
melanoblasts. The melanoblasts are supposed to be derived from the cells of neuro 
ectodermal origin during the embryonic life. After birth, these cells migrate to their 
definitive position. The melanocytes appear as clear cells within the basal cell layer of the 
epidermis and show dendritic processes after special staining. These processes come in 
contact with similiar process of other melanocytes and epithelial cells through which the 
melanin pigments are donated to the basal cells of epidermis. The dermis of normal skin 
also shows macrophages containing melanin pigments known as melanophores, which are 
incapable to produce the melanin pigments. 
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CAUSES OF HYPOPIGMENTATION: 
Generalised depigmentation is found mostly in albinos. In this case, the 
characteristic dendritic melanocytes are present in the skin, but they are unable to produce 
melanin pigment due to defective tyrosinase activity. In albinism, the skin looks milky 
white, the hairs are pale looking and the iris is transparent. The generalized pallor is also 
noticed in panhypopituitiarism, male eunuchoidism and phenyl ketonuria. 
 
Localised depigmentation is often noticed in the skin of patterned leucoderma. The 
white patches on the skin may be quite extensive and the condition is inherited as an 
autosomal dominant character.Sometimes sharply defined focal depigmented areas are 
found on skin of persons suffering from vitiligo. In the affected areas, melanocytes are 
absent and there is no trace of melanin. The condition is an acquired one and shows some 
familial tendency. 
 
Vitiligo in patients in whom the disease spreads very fast or those having halo-navi 
or malignant melanoma is believed to be based on auto-immune mechanisms, where auto 
antibodies or sensitized lymphocytes are supposed to act on the melanocytes. Trauma on 
the skin including that produced by scratching can lead to depigmentation of the skin even 
when it does not lead to ulceration. Leucoderma is also commonly seen on the flanks of 
ladies wearing tight petticoat strings where the prolonged pressure is presumed to lead to 
depigmentation. Sometimes vitiligo can be caused by the action of monobenzyle either on 
hydroquinone present in the slippers, gloves (or) other articles made of rubber or used as a 
depigmenting agent in the form of an irritant for pigmentary disorders. Recently vitiligo has 
also been observed to occur from plastic slippers as well as plastic ‗hindis‘. 
 
However most people with vitiligo have no other autoimmune disease. Vitiligo may 
also be hereditary, that is, it can run in families. Children whose parents have the disorder 
are more likely to develop vitiligo. However, most children will not get vitiligo even if a 
parent has it, and most people with vitiligo do not have a family history of the disorder. 
 
CLINICAL FEATURES: 
 In this condition patches of skin lose their pigment and become perfectly white, 
though no other changes take place in them and particularly there is no scaling. 
 Vitiligo may occur in either sex. 
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 The white patches may appear on any part of the skin but commonest on the face, 
neck, hands and wrist, lower abdomen and thighs and may be precipitates by trauma 
to the skin. 
 They may be of any size or shape and are usually though not always, roughly 
symmetrical. 
 They slowly increase in size until large areas of the skin are completely discoloured. 
 The remaining small patches of normal skin may then be mistaken for pigmented 
areas. The mistake may be avoided by remembering that the vitiligo areas have 
convex margins and the normal areas therefore have concave ones. 
 When vitiligo occurs on a hairy area such as eyebrows or pubis the hair on the white 
patch may also become white. 
 The depigmented areas are sometimes surrounded by an excess of pigmentation in 
the immediately adjoining skin but this appearance is often illusory and the result of 
visual contrast. 
 Vitiligo is most noticeable in the summer when the normal skin is tanned by the sun. 
 Vitiligo sometimes disappears spontaneously after months or years but more usually 
the conditions spreads slowly and may eventually involve nearly whole of the skin. 
 It is characterized by completely depigmented macules and patches of varying sizes 
and shapes. 
 There are no other changes except depigmentation. 
 Early lesions may be pale white and ill defined. At this stage, Wood‘s lamp helps to 
confirm the diagnosis. Patches enlarge slowly and may affect the whole body. 
 Any part of the body can be affected but the sites of predilection are the face, dorsa 
of fingers and hands, wrist and the legs. 
 Involvement of mucous membrane especially the lip is not uncommon; it can 
precede cutaneous involvement by years. 
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CLINICAL CRITERIA FOR CLASSIFICATION OF VITILIGO: 
Stages of Clinical Features: 
 
Active (V1) (i)   New lesions developing 
 (ii)  Lesions increasing in size 
 (iii) Border ill-defined 
Quiescent (V2) (i)   No new lesions developing 
 (ii)  Lesions stationary in size 
 (iii) Border hyper pigmented and well-defined. 
Improving (V3) (i) Lesions decreasing in size 
 (ii)  No new lesions developing 
(iii) Border defined and signs of spontaneous regimentation 
 
Zosteriform: Unilateral distribution of lesions, preferably along the course of nerves. 
Besides typing the stage of disease, it is useful to decide the variety 
(acral,Vulgaris,Zosteriform), severity (Localized or extensive) and acuity (insidious or 
galloping) of vitiligo. 
 
DIAGNOSIS: 
 The distribution, the age of onset and the hyperpigmented border will suggest the 
diagnosis. 
 It is usually apparent; in doubtful and early case, Wood‘s lamp is of great help in 
diagnosis. 
 In piebaldism the lesions are present at birth, are usually confined to the head and trunk 
and rarely show a hyperpigmented border. 
 Careful examination of the texture of the unpigmented skin should exclude lichen 
sclerosus and scleroderma. 
 Post-inflammatory leucoderma, which is frequent in the darker races, shows an irregular 
mottling of hyperpigmented and hypopigmented blotches. 
 Hypomelanosis of the affected skin is commonly seen in pityriasis alba, producing 
slightly scaly areas with rather ill-defined edges of children‘s faces. 
 Hypopigmented, slightly scaly macules are seen in pityriasis versicolor. 
 Vitiliginous areas are milky white while other lacks this milky white colouration. 
 Stationary patches are well-defined and have hyperpigmented borders. 
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 Absence of scaling, crusting and itching help to eliminate seborrhoeids and pityriasis 
versicolor. 
 These areas often fluorescence a golden yellow when examined under a Wood‘s lamp. 
The hypomelanotic macules in leprosy are anaesthetic. 
 Examination of the skin in long wave UVR helps distinguish whether there is total 
depigmentation (as in Vitiligo) or not. It may also detect areas of depigmentation not 
easily seen in ordinary daylight, as well as detecting a lemon-yellow fluorescence seen 
in some cases of pityriasis versicolor. 
 
PROGNOSIS: 
It has improved considerably in recent years because of better understanding of etiological 
factors and advances made in therapy. 
Following conditions are said to be of poor prognosis. 
1) Poor nutritional state or digestion, use of broad - spectrum antibiotics over long 
period, emotional stress and nervous debility. 
2) Presence of vitiligo on resistant sites like the hands and the feet, front of wrists, the 
elbow, the waist, the eyelids and lips. 
3) Depigmented hair in vitiliginous areas. 
 
Causes of Localised Hypopigmentation 
 
Vitiligo Destruction of melanocytes; common; acquired, multiple 
sharply defined nonpigmented patches anywhere. 
Pityriasis versicolor Superficial fungus infection leading to disturbance in pigment 
production, common multiple pale scaling patches on trunk 
Pityrisis alba Mild patchy eczema of the face in children causing a 
disturbance in pigment production. 
Leprosy One or several paler macules on trunk or limbs that are hypo 
aesthetic. 
White macules of 
affecting tuberous 
sclerosis 
Uncommon development of anomaly of CNS, connective tissue 
and skin; several ―maple leaf‖ shaped hypopigmented macules. 
Post inflammatory 
hypopigmentation 
After inflammatory skin disease (after eczema or trauma to the 
skin; irregular in shape and in depth of pallor). 
Naevous  anaemicus Rare developmental solitary white patch usually on trunk; 
thought to have vascular basis. 
Chemical toxicity May look very much like vitiligo; seen in workers in rubber 
industry exposed to parateriary benzyltoluence. 
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DIFFERENTIAL DIAGNOSIS OF THE IMPORTANT DEPIGMENTARY   
DISORDERS: 
 
Distinguish 
Features 
Albinism 
Naevus 
Depigmentosus 
Vitiligo Leprosy Pityriasis 
Age 
Congential 
present at 
birth 
Congential-
present at birth 
Acquired Any age Any age 
Distribution 
Complete 
(or) partial 
Unilateral Any area Any area 
Trunk, Neck, and 
Face 
Course Stationary 
Does not 
increase in size 
or changing 
shape 
Progressive Progressive 
Progressive, 
worse  in 
monsoon and 
summer 
Hyperpig 
mentary 
border 
Nil Nil Present Inflammatory Nil 
Heredofamilial Hereditary Not hereditary Nil Nil Nil 
Other features 
Hair and 
eyes may 
be 
affected 
Nil Nil 
Anaesthesia 
thickened 
nerves, nasal, 
bleeding slit 
smear and 
biopsy 
Furfuraceous like 
dandruff, scaling 
in head macules 
and large 
patches. 
 
 
43 
 
VITILIGO AREA SEVERITY INDEX (VASI) 
 
Its name is an adoption from PASI score in psoriasis. The percentage of vitiligo 
involvement is calculated in terms of hand units. One hand unit is approximately equivalent 
to 1% of the total body surface area. The degree of pigmentation is estimated to the nearest 
of one of the following percentages: 100% - complete depigmentation, no pigment is 
present; 90% - specks of pigment present; 75% - depigmented area exceeds the pigmented 
area; 50% - pigmented and depigmented areas are equal; 25% - pigmented area exceeds 
depigmented area; and 10% - only specks of depigmentation present. The VASI for each 
body region is determined by the product of the area of vitiligo in hand units and the extent 
of depigmentation within each hand unit measured patch.Total body VASI = S All body 
sites [Hand Units] ´ [Residual depigmentation]. 
 
 
DEPIGMENTATION VISUAL SCALE: 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4: Depigmentation visual scale 
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VASI score ~−50 Very much worse 
VASI score -50 to -25 Much worse 
VASI score -25 to -10 Worse 
VASI score -10 to 0 Minimally worse 
VASI score 0 to +10 Minimally improved 
VASI score +10 to 25 Improved 
VASI score 25 to 50 Much improved 
VASI score +50~ Very much improved 
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DRUG REVIEW 
I. PARANGIPATTAI CHOORANAM: 
i) PARANGI PATTAI: 
Botanical name  :  Smilax china Linn. 
English name  : China root 
Family    :  Liliaceae 
Part used    :  Tuber  
Organoleptic Characters: 
Suvai      :  Inippu  
Thanmai    :  Thatpam 
Pirivu     :  Inippu 
nghJ Fzk;: 
jhfk; gythje; jhJel;lk; Gz;gpsit 
Nkfq; fbfpue;jp tPo;%ye; - NjfKld; 
Fl;il gfe;jNkw; nfhs;tkdk; Nghk;gwq;fpg; 
gl;ilapid Ar;rhpj;Jg; ghh;. 
    -Njiuah; Fzthflk;. 
Chemical constituents: 
 Saponins, D - mannitol, Stigmasterol, oleanolic acid, Queretaroic acid, 
Serratagenic acid, Sitosterol, Clerosterol identified as 5, 25- stimastadien-3β o, 
Clerodone as 3β- hydroxyl- lupan 12- one, Β- sitosterol, Lupeol, A steroidal 
glycoside, Phytosterols, Ferulic acid, Arabinose, Scutellarcin, Baicalein , Serratin 
and Ursolic acid.   
Ref: Praveen Kumar A et al / Int. J. Res. Ayurveda Pharm. 4(2), Mar – Apr 2013.   
 
Actions:  
 Alternative  
 Antisyphilitic  
 Aphrodisiac  
 
ii) KARUNTHULASI: 
Botanical name  :  Ocimum tenuiflorum Linn. 
English name  :  Holy basil 
Family    :  Lamiaceae 
Part used    :  Leaf 
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Organoleptic Characters: 
Suvai      :  Karppu 
Thanmai    :  Thatpam 
Pirivu      :  Karppu 
 
nghJf; Fzk;: 
 ―,UknyhL neQ;rp ypOg;Gr;R thrk; 
 fpUkp ryNjhlk; Nfty; - kUkr; 
 rsp&l;ir #iytplk; rd;dpapit Nghf;Fk; 
 jspuhh; fUe;Jsrp jhd;.‖ 
 
Chemical constituents: 
 
 Linoleic, lauric, myristic, oleic, palmitic and stearic acids 
 β sitosterol. 
 
Actions: 
 Stimulant 
 Expectorant 
 Diaphoretic 
 
II. ANNABEDHI CHENDURAM: 
i) ANNABEDHI ( IRON SULPHATE):  
Other Names: 
 Green vitriol 
 Ferrous sulfate   
 Iron Vitrol   
 Copperas  
 Melanterite   
 Szomolnokite 
Natural occurrences: 
 Mikasaite, a mixed iron-aluminium sulfate of chemical formula (Fe3+, 
Al3+)2(SO4)3[3] is the name of mineralogical form of iron(III) sulfate.  
 This anhydrous form occurs very rarely and is connected with coal fires.  
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 The hydrates are more common, with coquimbite (nonahydrate) as 
probably the most often met among them.  
 Paracoquimbite is the other, rarely met natural nonahydrate. Kornelite 
(heptahydrate) and quenstedtite (decahydrate) are rarely found.  
 Lausenite (hexa- or pentahydrate) is a doubtful species. All the mentioned 
natural hydrates are unstable compounds connected with Fe-bearing 
primary minerals (mainly pyrite and marcasite) oxidation in ore beds.  
 In the solutions of the ore beds oxidation zones the iron(III) sulfate is also 
an important oxidative agent.  
 Ironsulfate is the chemical compound with the formula Fe2(SO4)3, the 
sulfate of trivalent iron.  
 Usually yellow, it is a rhombic crystalline salt and soluble in water at 
room temperature. 
 It is used in dyeing as a mordant, and as a coagulant for industrial wastes.  
 It is also used in pigments, and in pickling baths for aluminum and steel.  
 Medically it is used as an astringent and styptic. 
 
Physical Properties: 
 Molecular formula :  FeSO4  
 Molar mass  :  151.908g/mol (anhydrous)  
   169.92g/mol(monohydrate)  
   278.05 g/mol (heptahydrate)  
 Appearance  :  Blue/green or white crystals  
 Odour   :  Odourless  
 Density  :  2.84g/cm3 (anhydrous)  
   2.2g/cm3 (pentahydrate) 
   1.898 g/cm3 (heptahydrate) 
 Melting point  :  70 °C (dehydration of heptahydrate)  
   400 °C (decomp)  
 Solubility in water :   25.6 g/100mL (anhydrous)  
   48.6 g/100 mL (heptahydrate) (50 °C)  
 Solubility  :   Negligible in alcohol  
 Refractive index (nD)  : 1.536 (pentahydrate)  
   1.478 (heptahydrate) 
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GUNAPADAM ASPECT: 
 
 md;dNgjp RNjr kUe;Jf; filfspy; fpilf;Fk; 
 ,Uk;Gf; fk;gpAld;> fe;jfj; jpuhtfk; Nrh;j;Jr; nra;fpd;w ,r;ruf;F 
fl;bfshAk;> gr;ir epwkhAk; ,Uf;Fk;. 
 md;dNgjp vd;w jhJ fhrPrk; kiyapy; cw;gj;jpahfpwnjd;Wk; fWg;G kQ;rs;> 
nts;is Mfpa %d;W tpjkhFk; vd;Wk; Nghfh; E}y; $Wk;. 
 ,J ePhpy; fiuAk;. 
 rhuhaj;jpy; fiuahJ. 
 ,jd;Nky; fhw;Wg;gl;lhy; ntz;ikahd J}sha;tpLk;. 
 
Vernacular Names:  
 Eng   -  Green Vitroil  
 Green   -  Copperas  
 Sans      -  Kasosa  
 Fr  -  Sulphate Ferreux  
 Ger   -   Schwefel Saures  
 Ben   -  Hirakas  
 Can   -  Hirakasa  
 Arab   -   Zaje Asfara  
 Hind   -   Haratutia  
 Guj   -   Harakasis  
 Punj   -   Sangi-sabz10  
 Malay  -   Madukalpa  
 Tel  -       Tagramu  
 
Organoleptic Character: 
 Taste       -   Jth;g;G 
 Bio transformation -  ntg;gk; 
 
nghJf; Fzk;: 
 ―KistpuzQ; #iyke;j Kl;lhikf; fl;b 
 tpisawd;k NfhjuNeha; tPl;Lk; - tiskiyNghw; 
  fhl;Lkd;de; jd;idf; fzj;jpw; rykhf;fpf; 
 fhl;Lkd;d NgjpaJ fhz;‖ 
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Actions: 
 Nutrient 
 Astringent 
 Deodorant 
 Anthelmintic 
 Antiperiodic 
 
ii) LEMON: 
 Botanical Name : Citrus limon Linn. 
 English name   :  Lime 
 Family   :  Rutaceae 
 Part Used  :  Leaf, Fruit,Unripe fruit,Fruit juice, Oil.  
  
Organoleptic characters: 
 Suvai      :  Pulippu 
 Thanmai    :  Veppam 
 Pirivu      :  Karppu 
 
nghJ Fzk;: 
 
 ―ke;jphpf;F ke;jphpaha; kd;dDf;F kd;dnddj; 
 je;jphpf;Fkpj;jpud;Nghw; rhUNk – Ke;jtU 
 fk;gPu kha;r;rpuf;fpd; nfz;zpakha; thflh;f;Fr; 
 rk;gPu khnkYkpr; ir.‖ 
 
Actions: 
 Refridgerant 
 Rubefacient 
 Carminative 
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INGREDIENTS OF PARANGIPATTAI CHOORANAM 
 
 
 
  Fig 5(i):     Fig 5 (ii): 
Parangipattai (SMILAX CHINA)  Karunthulasi (OCIMUM TENUIFLORUM) 
 
  
   Fig 5 (iii)Parangipattai chooranam  
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INGREDIENTS OF ANNABEDHI CHENDURAM 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Fig 6(i): Annabedhi    Fig 6 (ii): Lemon (CITRUS LIMON) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6 (iii): Annabedhi chenduram 
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MATERIALS AND METHODS 
 
AProtocol was prepared and submittedbefore Institutional Ethical Committee 
(IEC)ofNationalInstituteofSiddha. Date of IEC approval & IEC number is 
NIS/IEC/2016/11-24/14.10.2016. The trial was registered in Clinical trial Registry of India 
with Reg.NoCTRI/2017/06/008755 [Registered on: 05/06/2017].Afterobtaining approval 
from thecommittee, the clinical studyon VENPULLI (Vitiligo) in children with the trialdrug 
PARANGIPATTAI CHOORANAM (internal) and ANNABEDHI CHENDURAM 
(external) wascarriedoutasperthe protocol. 
 
The trial drug “PARANGIPATTAI CHOORANAM (internal) and ANNABEDHI 
CHENDURAM (external)” was given for 48 days. For OP patients before and after 
treatment the clinical assessment is done and prognosis was noted. After the end of the 
treatment, the patient was advised to visit the OPD for another 1 month for follow-up.  
 
METHODOLOGY: 
1. INGREDIENTS AND PREPARATION OF THE TRIAL DRUG: 
A. INTERNAL MEDICINE: 
 
NAME                 :   PARANGIPATTAI CHOORANAM. 
 
INGREDIENTS:   
          1. PARANGIPATTAI (SMILAX CHINA Linn.)                  - 1 PART  
          2. KARUNTHULASI (OCIMUM TENUIFLORUM Linn.)  - 1 PART 
 
SOURCE OF TRIAL MEDICINE:          
      The required drugs were purchased from a well reputed country shop and raw drugs 
were authenticated by the medicinal botanist of NIS. The medicine was prepared in 
Gunapadam lab of National Institute of Siddha after proper purification. The prepared 
medicine were also be authenticated by the concerned Head of the Dept for its 
completeness.All the ingredients mentioned in the formulation is purified as per the 
direction described in the Siddha literature. 
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PURIFICATION OF RAW DRUG: 
 Parangipattai: The drug was boiled in milk for 3 hours then dried well. 
 
PREPARATION:   
Parangipattai was soaked in equal amount of Karunthulasi juice and kept in sunlight 
until it was dried. Then it is grinded into fine powder and filtered by the process by 
vasthirakaayam. 
 
B. EXTERNAL MEDICINE: 
 
NAME                 : ANNABEDHI CHENDURAM. 
 
INGREDIENTS:   
          1. ANNABEDHI 
          2. LEMON JUICE 
 
PURIFICATION OF ANNABEDHI: 
 Anabedhi was grinded with Chunnaneer in Kalvam for 6 hours. 
 
PREPARATION: 
 
Purified Annabedhi was grinded with lemon juice in kalvam and kept in pudam to 
prepare it as a chenduram. 
 
STUDY DESIGN: 
Study Type   : An open clinical trial 
 
Study Place  :   Department of Kuzhanthai Maruthuvam, 
 Ayothidass Pandithar Hospital (Opd & Ipd),  
    National Institute of Siddha, 
    Tambaram Sanatorium  
    Chennai-47.  
 
Study Period   : 24 Months 
 
Number of Patients   : 30 Patients (Both male and female children)  
54 
 
Drug Formulation: 
 
 INTERNAL MEDICINE  - PARANGIPATTAI CHOORANAM (INTERNAL) 
 EXTERNAL MEDICINE - ANNABEDHI CHENDURAM (EXTERNAL) 
 
Internal Medicine: 
NAME                  :  PARANGIPATTAI CHOORANAM. 
DOSAGE              :  ½ - 1 gram (bd). 
VEHICLE             :  Sakkarai (palm jaggery). 
DURATION          :  1Mandalam (48 days). 
DISPENSING         :  The prepared chooranam was dispensed in a pure container with 
 required details and investigators contact number. 
REFERENCE        :  SIDDHA VAITHIYA THIRATTU (Pg.no:221). 
 
External Medicine: 
NAME                   :   ANNABEDHI CHENDURAM. 
APPLICATION     :  With lemon juice 
DURATION          :  1 Mandalam (48 days). 
DISPENSING        :  The prepared chenduram was dispensed in a pure container with 
 required details and investigators contact number. 
REFERENCE        :  GUNAPAADAM THATHU JEEVA VAGUPU (Pg.no:528) 
 
INCLUSION CRITERIA                                                                        
 Age: 5 – 12 years 
 Sex: Both male and female children. 
 Hypo pigmented patches with hyper pigmented border without any structural changes 
in any part of the body. 
 Patients who are willing to stay in IPD Ward for atleast 10 days or willing to attend 
OP Dept. as required. 
 Patient‘s informant / Parent willing to sign the informed consent stating that he/she 
will consciously stick to the treatment during 48 days but can opt out of the trial of 
his / her own conscious discretion.  
 Willing to cooperate for taking photographs whenever required with his\her consent. 
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EXCLUSION CRITERIA  
 Albinism  
 Dermatological aspect of Leprosy 
 Tinea versicolor 
 Burn scars 
 Dermatological aspect of Addison‘s diseases 
 Post inflammatory hypopigmentation 
 Pityriasis alba 
 Alopecia aerate 
 Chemical leukoderma 
 
WITHDRAWL CRITERIA 
 Exacerbation of symptoms and signs 
 If any adverse reactions and unwanted symptoms occurred during the drug trial. 
 Intolerance to the drug. 
 Patient turned unwilling to continue in the course of clinical trial. 
 Occurrence of any serious illness.  
 
STUDY ENROLMENT: 
 In this study, patients reporting at the NIS OPD were examined clinically for 
enrolling in the study based on inclusion and exclusion criteria. 
 The patients who are to be enrolled were informed about the study, trial drug, 
possible outcomes and the objectives of the study in the language and terms 
understandable to them. 
 After ascertaining the patient‘s informant willingness, informed consent (Form II) 
was obtained in writing from their parents in the consent form. 
 All these patients were given investigators phone number so as to report easily if any 
complications arise. 
 Complete clinical history, complaints and duration, examination findings—all were 
recorded in the prescribed Proforma in the history and clinical assessment forms 
separately. Screening Form - I is filled up. Form III was used for recording the 
patient‘s history, laboratory investigations and clinical examination of signs and 
symptoms respectively. 
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 Patients were advised to take the trial drug and appropriate dietary advice (Form-V) 
is given according to the patient‘s perfect understanding. 
 
CONDUCT OF THE STUDY: 
 The trial drug ―PARANGIPATTAI CHOORANAM (internal) and ANNABEDHI 
CHENDURAM (external)‖ was given for 48 days (twice a day),OP patients should 
visit the hospital once in 7 days. 
 At each clinical visit clinical assessment was done and prognosis was noted.  
 For IP patients who were not in a situation to stay in the hospital for a long time they 
were advised to attend the OPD for further follow up. 
 Siddha investigations like Neerkuri and Neikuri were carried out. 
 After the end of the treatment the patient were advised to visit the OPD for one week 
for follow up. 
 If any trial patients who failed to collect the trial drug on the prescribed day but was 
willing to continue in the trial from the next day or two, he/she was allowed, but 
defaulters more than one week and more will not be allowed to continue and 
withdrawn from the study and a fresh case was included. 
 
CLINICAL ASSESSMENT: 
To assess the improvement by VASI Score (In annexure C). 
 
SIDDHA ASSESSMENT: 
 Nilam 
 Kalam 
 Uyirthathukkal 
 Udal thathukkal     
 Envagai thervugal 
 Neerkuri 
 Neikkuri 
 
OUT COME: 
Efficacy of the trial drug measured by VASI Score. 
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Data Management: 
After enrolling the patient in the study, a separate file for each patient was opened 
and all forms were filed in the file. Study no, and Patient no, were entered on the top of file 
for easy identification.Whenever study patient visits OPD during the study period, the 
respective patient file was taken and necessary recordings were made at the assessment for 
or other suitable form. 
 
The data recordings in all forms were monitored and scrutinized by HOD, Dept. of 
Kuzhanthai Maruthuvam.Data analysis was done with the help of senior research officer 
(statics) of NIS. 
 
Adverse Effect/Serious Effect Management: 
 
If the trial patient develops any adverse reaction such as continuous vomiting, 
diarrhoea, high fever, rashes, he/she would be immediately withdrawn from the trial and 
proper management will be given in OPD of National Institute of Siddha. The details of 
adverse reactions will be recorded in prescribed Pharmacovigilance form and the same will 
be reported to Regional Pharmacovigilance centre. 
 
Ethical Issues: 
 
1. No other external or internal medicines are used. 
2. The data collected from the patient‘s informant are recorded.  The patient‘s 
informant is informed about the diagnosis, treatment and follow-up. 
3. After the consent of the patient‘s informant (through consent form), patinet‘s are 
enrolled in the study. 
4. Informed consent is obtained from the patient‘s informant explaining in the 
understandable language to the patient‘s informant. 
5. Treatment would be provided free of cost. 
6. In conditions of treatment failure, adverse reactions, patients are given alternative 
treatment at the National Institute of Siddha with full care. 
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DATA COLLECTION FORMS: 
 FORM I - SCREENING & SELECTION PROFORMA 
 FORM II - CONSENT FORM 
 FORM II A     -  ASSENT FORM 
 FORM III       - CASE RECORD FORM 
 FORM IV       -  INFORMATION SHEET. 
 FORM V - DIETARY FORM  
 FORM VI        -  DRUG COMPLAINCE 
 FORM VII       - ADVERSE EFFECT  
 FORM VIII     - WITHDRAWL FORM 
 FORM IX       -  PHARMOCOVIGILENCE 
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ANALYTICAL SPECIFICATIONS FOR TRAIL DRUG 
PHYSICOCHEMICAL ANALYSIS 
Particle size 
 Particle size determination was carried out by optical microscopic method. In which 
the sample were dissolved in the sterile distilled water (app 1/100th dilution). Diluted 
sample were mounted on the slide and fixed with stage of appropriate location. Light 
microscopic image were drawn with scale micrometre to arrive at the average particle size. 
Minimum 30 observations were made to ascertain the mean average particle size of the 
sample. 
 
Percentage Loss on Drying 
10gm of test drug was accurately weighed in evaporating dish .The sample was 
dried at 105
o
C for 5 hours and then weighed. 
Percentage loss in drying = Loss of weight of sample/ Wt of the sample X 100 
 
Determination of Total Ash 
3 g of test drug was accurately weighed in silica dish and incinerated at the furnace 
at a temperature of 400 ºC until it turns white in color which indicates absence of carbon. 
Percentage of total ash will be calculated with reference to the weight of air-dried drug. 
Total Ash = Weight of Ash/Wt of the Crude drug taken X 100 
 
Determination of Acid Insoluble Ash 
The ash obtained by total ash test was boiled with 25 ml of dilute hydrochloric acid 
for 6mins. Then the insoluble matter is collected in crucible and will be washed with hot 
water and ignited to constant weight. Percentage of acid insoluble ash will be calculated 
with reference to the weight of air-dried ash. 
Acid insoluble Ash = Weight of Ash/Wt of the Crude drug taken X 100 
 
Determination of Water Soluble Ash 
The ash obtained by total ash test was boiled with 25 ml of water for 5 mins. The 
insoluble matter is collected in crucible and will be washed with hot water, and ignite for 
15mins at a temperature not exceeding 450ºC. Weight of the insoluble matter will be 
subtracted from the weight of the ash; the difference in weight represents the water soluble 
ash. Calculate the percentage of water-soluble ash with reference to the air-dried drug. 
Water Soluble Ash = Weight of Ash/Wt of the Crude drug taken X 100 
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Determination of Alcohol Soluble Extractive 
About 5 g of test sample was macerated with 100 ml of Alcohol in a closed flask for 
twenty-four hours, shaking frequently during six hours and allowing to stand for eighteen 
hours. Filter rapidly, taking precautions against loss of solvent, evaporate 25 ml of the 
filtrate to dryness in a tared flat bottomed shallow dish, and dry at 105ºC, to constant weight 
and weigh. Calculate the percentage of alcohol-soluble extractive with reference to the air-
dried drug. 
Alcohol sol extract = Weight of Extract/ Wt of the Sample taken X 100 
 
Determination of Water Soluble Extractive 
About 5 g of the test sample was macerated with 100 ml of chloroform water in a 
closed flask for twenty-four hours, shaking frequently during six hours and allowing to 
stand and for eighteen hours. Filter rapidly, taking precautions against loss of solvent, 
evaporate 25 ml of the filtrate to dryness in a tared flat bottomed shallow dish, and dry at 
105ºC, to constant weight and weigh. Calculate the percentage of water-soluble extractive 
with reference to the air-dried drug. 
Water soluble extract = Weight of Extract/ Wt of the Sample taken X 100 
 
Determination of pH 
About 5 g of test sample was dissolved in 25ml of distilled water and filtered the 
resultant solution is allowed to stand for 30 mins and the subjected to pH evaluation. 
 
Thin Layer Chromatography and High Performance Thin Layer Chromatography: 
1. TLC Analysis: 
Test sample was subjected to thin layer chromatography (TLC) as per conventional one 
dimensional ascending method using silica gel 60F254, 7X6 cm (Merck) were cut with 
ordinary household scissors. Plate markings were made with soft pencil. Micro pipette were 
used to spot the sample for TLC applied sample volume 10-micro litre by using pipette at 
distance of 1 cm at 5 tracks. In the twin trough chamber with different solvent system 
Toluene: Ethyl Acetate: Acetic Acid (1.5:1:0.5) After the run plates are dried and was 
observed using visible light Shortwave UV light 254nm and light long-wave UV light 365 
nm. 
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2. High Performance Thin Layer Chromatography Analysis: 
 
HPTLC method is a modern sophisticated and automated separation technique derived 
from TLC. Pre-coated HPTLC graded plates and auto sampler was used to achieve 
precision, sensitive, significant separation both qualitatively and quantitatively. High 
performance thin layer chromatography (HPTLC) is a valuable quality assessment tool for 
the evaluation of botanical materials efficiently and cost effectively. HPTLC method offers 
high degree of selectivity, sensitivity and rapidity combined with single-step sample 
preparation. In addition it is a reliable method for the quantitation of nano grams level of 
samples. Thus this method can be conveniently adopted for routine quality control analysis. 
It provides chromatographic fingerprint of phytochemicals which is suitable for confirming 
the identity and purity of medicinal plant raw materials. 
 
(a) Chromatogram Development: 
It was carried out in CAMAG Twin Trough chambers. Sample elution was carried 
out according to the adsorption capability of the component to be analysed. After elution, 
plates were taken out of the chamber and dried. 
 
(b) Scanning: 
Plates were scanned under UV at 366nm. The data obtained from scanning were 
brought into integration through CAMAG software. Chromatographic finger print was 
developed for the detection of phyto constituents present in each extract and Rf values were 
tabulated. 
 
Heavy/Toxic Metal Analysis by AAS: 
Methodology: 
 Atomic Absorption Spectrometry (AAS) is a very common and reliable technique 
for detecting metals and metalloids in environmental samples. The total heavy metal content 
of the sample PPC was performed by Atomic Absorption Spectrometry (AAS) Model AA 
240 Series in order to determine the heavy metals such as mercury, arsenic, lead and 
cadmium concentrations in the test sample PPC. 
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Sample Digestion: 
Test sample PPC digested with 1mol/L HCl for determination of arsenic and 
mercury. Similarly for the determination of lead and cadmium the sample were digested 
with 1mol/L of HNO3.  
 
Standard reparation: 
As & Hg- 100 ppm sample in 1mol/L HCl   
Cd & Pb- 100 ppm sample in 1mol/L HNO3 
 
Microbial contamination by Pour Plate Method: 
Objective: 
The pour plate techniques were adopted to determine the sterility of the product. 
Contaminated / un sterile sample (formulation) when come in contact with the nutrition rich 
medium it promotes the growth of the organism and after stipulated period of incubation the 
growth of the organism was identified by characteristic pattern of colonies. The colonies are 
referred to as Colony Forming Units (CFUs).   
 
Methodology: 
About 1ml of the test sample was inoculated in sterile petri dish to which about 15 
mL of molten agar 45
o
C were added. Agar and sample were mixed thoroughly by tilting and 
swirling the dish. Agar was allowed to completely gel without disturbing it. (About 10 
minutes). Plates were then inverted and incubated at 37o C for 24-48 hours. Grown colonies 
of organism was then counted and calculated for CFU. 
Observation: 
No growth was observed after incubation period reveals the absence of specific 
pathogen.
 
Test for Specific Pathogen: 
Methodology: 
One part of the test sample was dissolved in 9 mL of sterile distilled water and the 
test sample was directly inoculated in to the specific pathogen medium (EMB, DCC, 
Mannitol, Cetrimide) by pour plate method. The plates were incubated at 37
o
C for 24 - 72h 
for observation. Presence of specific pathogen identified by their characteristic colour with 
respect to pattern of colony formation in each differential media. 
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Analysis of Pesticides Organochlorine, Organophosphorus and Pyrethroids: 
Extraction: 
About 10 g of test substance were extracted with 100 ml of acetone and followed by 
homogenization for brief period. Further filtration was allowed and subsequent addition of 
acetone to the test mixture. Heating of test sample was performed using a rotary evaporator 
at a temperature not exceeding 40ºC until the solvent has almost completely evaporated. To 
the residue add a few millilitres of toluene R and heat again until the acetone is completely 
removed. Resultant residue will be dissolved using toluene and filtered through membrane 
filter. 
Aflatoxin Assay by TLC (B1,B2,G1,G2): 
Solvent: 
Standard samples was dissolved in a mixture of chloroform and acetonitrile (9.8 : 
0.2) to obtain a solution having concentrations of 0.5 µg per ml each of aflatoxin B1 and 
aflatoxin G1 and 0.1 µg per ml each of aflatoxin B2 and aflatoxin G2.   
 
Test solution: Concentration 1 µg per ml. 
Procedure: 
Standard aflatoxin was applied on to the surface to pre coated TLC plate in the volume 
of 2.5 µL, 5 µL, 7.5 µL and 10 µL. Similarly the test sample was placed and Allow the 
spots to dry and develop the chromatogram in an unsaturated chamber containing a solvent 
system consisting of a mixture of chloroform, acetone and isopropyl alcohol (85 : 10 : 5) 
until the solvent front has moved not less than 15 cm from the origin. Remove the plate 
from the developing chamber, mark the solvent from and allow the plate to air-dry. Locate 
the spots on the plate by examination under UV light at 365 nm. 
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BIOCHEMICAL ANALYSIS 
 
Biochemical Analysis of Parangipattai chooranamwas done at the Biochemistry lab 
at National Institute of Siddha, Chennai by the method of Kolkate. 
 
Preparation of Extract: 
5ml of sample was taken in a 250ml clean beaker and added with 50ml of distilled 
water. Then it is boiled well for about 10 minutes. Then it is cooled and filtered in a 100ml 
volumetric flask and made up to 100ml with distilled water. This preparation is used for the 
qualitative analysis of acidic/basic radicals and biochemical constituents in it. 
 
PROCEDURE: 
 
I. Test for Acid Radicals 
Test for Sulphate: 
2ml of the above prepared extract was taken in a test tube to this added 2ml of 4% 
dil ammonium oxalate solution 
 
Test for chloride: 
2ml of the above prepared extracts was added with 2ml of dil.HCl is added until the 
effervescence ceases off. 
 
Test for Phosphate: 
2ml of the extract were treated with 2ml of dil.ammonium molybdate solution and 
2ml of con.HNo3. 
 
Test for carbonate: 
2ml of the extract was treated with 2ml of dil. magnesium sulphate solution. 
 
Test for Nitrate: 
1gm of the extract was heated with copper turning and concentrated H2So4 and 
viewed the test tube vertically down. 
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II.Test for Basic radicals 
Test for lead: 
2ml of the extract was added with 2ml of dil.potassium iodine solution. 
 
Test for copper: 
One pinch (25mg) of extract was made into paste with con. HClin a watch glass and 
introduced into the non-luminuous part of the flame. 
 
Test for Aluminium: 
To the 2ml of extract dil.sodium hydroxide was added in 5 drops to excess. 
 
Test for Iron:  
a. To the 2ml of extract add 2ml of dil.ammonium solution  
b. To the 2ml of extract 2ml of thiocyanate solution and 2ml of con HNo3 is added. 
 
Test for Zinc: 
To 2ml of the extract dil.sodium hydroxide solution was added in 5 drops to excess 
and dil.ammonium chloride was added.  
 
Test for Calcium: 
To 2ml of the extract was added with 2ml of 4% dil.ammonium oxalate solution 
 
Test for Magnesium: 
To 2ml of extract dil.sodium hydroxide solution was added in drops to excess. 
 
Test for Ammonium: 
To 2ml of extract 1 ml of Nessler's reagent and excess of dil.sodium hydroxide 
solution are added. 
 
Test for Potassium: 
A pinch (25mg) of extract was treated off with 2ml of dil.sodium nitrite solution and 
then treated with 2ml of dil.cobalt nitrate in 30% dil.glacial acetic acid. 
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Test for Sodium: 
2 pinches (50mg) of the extract is made into paste by using HCl and introduced into 
the blue flame of Bunsen burner. 
 
Test for Mercury: 
2ml of the extract was treated with 2ml of dil.sodium hydroxide solution. 
 
Test for Arsenic: 
2ml of the extract was treated with 2ml of dil.sodium hydroxide solution 
 
III. Test for Phytochemical: 
 
Test for Starch: 
2ml of extract was treated with weak dil.Iodine solution. 
 
Test For Reducing Sugar: 
5ml of Benedict's qualitative solution was taken in a test tube and allowed to boil for 
2 minutes and added 8 to 10 drops of the extract and again boil it for 2 minutes. The colour 
changes are noted. 
 
Test for the Alkaloids: 
a) 2ml of the extract was treated with 2ml of dil.potassium Iodide solution. 
b) 2ml of the extract was treated with 2ml of dil.picric acid. 
c) 2ml of the extract was treated with 2ml of dil.phosphotungstic acid. 
Test for Tannic Acid: 
2ml of extract was treated with 2ml of dil.ferric chloride solution. 
 
Test for AminoAcid: 
2 drops of the extract was placed on a filter paper and dried well. 20ml of Burette 
reagent is added. 
 
Test for Coumarins:  
To the test sample, 1 ml of 10% sodium hydroxide was added. The presence of 
coumarins is indicated by the formation of yellow colour. 
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Test for Saponins:  
To the test sample, 5 ml of water was added and the tube was shaken vigorously. 
Copious lather formation indicates the presence of Saponins. 
 
Test for glycosides- Borntrager’s Test: 
Test drug is hydrolysed with concentrated hydrochloric acid for 2 hours on a water 
bath, filtered and the hydrolysate is subjected to the following tests. To 2 ml of filtered 
hydrolysate, 3 ml of chloroform is added and shaken, chloroform layer is separated and 
10% ammonia solution is added to it. Pink colour indicates presence of glycosides. 
 
Test for flavonoids: 
To the test sample about 5 ml of dilute ammonia solution were been added followed 
by addition of few drops of conc. Sulfuric acid. Appearance of yellow color indicates the 
presence of Flavonoids. 
 
Test for phenols:Lead acetate test:  
To the test sample; 3 ml of 10% lead acetate solution was added.  A bulky white 
precipitate indicated the presence of phenolic compounds. 
 
Test for steroids: 
To the test sample, 2ml of chloroform was added with few drops of conc. Sulphuric 
acid (3ml), and shaken well. The upper layer in the test tube was turns into red and 
sulphuric acid layer showed yellow with green fluorescence. It showed the presence of 
steroids. 
 
Triterpenoids: 
Liebermann–Burchard test: To the chloroform solution, few drops of acetic 
anhydride was added then mixed well. 1 ml concentrated sulphuric acid was added from the 
sides of the test tube, appearance of red ring indicates the presence of triterpenoids. 
 
Test for Cyanins: 
Anthocyanin: 
To the test sample, 1 ml of 2N sodium hydroxide was added and heated for 5 min at 
100ºC. Formation of bluish green colour indicates the presence of anthocyanin. 
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OBSERVATION AND RESULT 
 
PHYSICO-CHEMICAL ANALYSIS: 
 
Organoleptic characters: (Table 9) 
 
Sl.No Specification Character 
1 Colour Milky white 
2 Odour Mild 
3 Taste Bitter and sweet 
4 Consistency Very fine powder 
 
Physicochemical characters of Parangipattai chooranam: (Table 10) 
 
S.No Parameter Mean (n=3) SD 
1 Loss on Drying at 105 °C (%) 8.5  ±  2.80 
2 Total Ash (%)  0.55  ±  0.05 
3 Acid insoluble Ash (%) 0.32  ±  0.15 
4 Water Soluble Ash (%) 7.46  ±  0.72 
5 Alcohol Soluble Extractive (%) 34.44  ±  2.12 
6 Water soluble Extractive (%) 28.86  ±  0.81 
7 pH  4.8 
 
PARTICLE SIZE DETERMINATION: 
 
Microscopic observation of the particle size analysis reveals that the average particle 
size of the sample PPC was found to be 121.9± 45.24 µm further the sample PPC has 
particle with the size range of lowest 41.1 µm to highest 211.341.1 µm.  
 
Fig 7: Particle size determination 
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HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY: 
 
HPTLC finger printing analysis of the sample PPC reveals the presence of four 
prominent peaks corresponds to presence of four versatile phytocomponents present with in 
it. Rf value of the peaks ranges from 0.30 to 0.89.  Further the peak 2 occupies the major 
percentage of area of 38.78 % which denotes the abundant existence of such compound. 
Followed by this peak 3 and 1 occupies the percentage area of 31.34 and 16.90%. Peak 4 
occupies the percentage area of 13%  
 
HPTLC peak table: (Table 11) 
 
Peak 
Start 
Rf 
Start 
height 
Max 
Rf 
Max 
height 
Max 
% 
End 
Rf 
End 
height 
Area 
Area 
% 
1 0.30 12.0 0.31 17.2 16.90 0.33 5.0 179.5 13.42 
2 0.45 1.5 0.46 39.4 38.78 0.48 0.5 428.3 32.02 
3 0.49 0.3 0.50 31.9 31.34 0.53 0.1 413.9 30.95 
4 0.89 0.7 0.92 13.2 13.00 0.94 2.9 315.8 23.61 
 
 
Fig 8: HPTLC finger printing 
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HEAVY/TOXIC METAL ANALYSIS BY AAS: 
 
Results of the present investigation has clearly shows that the sample PPC has no 
traces of Mercury and hence it was considered that the heavy metals mercury was absent in 
the sample PPC. The level of arsenic, lead and cadmium was found to be 0.009 ppm, 0.150 
ppm and 0.009 ppm respectively. It was observed that all three reported heavy metals 
(arsenic, lead and cadmium) seem very less when compare to the allowed recommended 
limit. 
 
Table 12: Heavy metal analysis: 
 
Name of the Heavy 
Metal 
Absorption Max 
Λ max 
Result Analysis Maximum Limit 
Mercury 253.7nm BDL 1 ppm 
Lead 217.0 nm 0.150 ppm 10 ppm 
Arsenic 193.7 nm 0.009 ppm 3 ppm 
Cadmium 228.8 nm 0.009 ppm 0.3 ppm 
 
MICROBIAL CONTAMINATION BY POUR PLATE METHOD: (Table 13) 
 
No growth / colonies were observed in any of the plates inoculates with the test 
sample.  
 
Test Result Specification As per AYUSH/WHO 
Total Bacterial Count Absent NMT 10
5
CFU/g As per AYUSH specification 
Total Fungal Count Absent NMT 103CFU/g 
 
 
 
Fig 9: Microbial contamination by Pour plate method. 
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TEST FOR SPECIFIC PATHOGEN :(Table 14) 
 
No growth / colonies were observed in any of the plates inoculated with the test 
sample. 
 
Organism Specification Result Method 
E-coli Absent Absent As per AYUSH 
specification 
Salmonella Absent Absent 
Staphylococcus Aureus Absent Absent 
Pseudomonas Aeruginosa Absent Absent 
 
 
 
Fig 10(i): Culture plate with E-coli and Salmonella specific medium. 
 
 
 
Fig 10 (ii): Culture plate with Staphylococcus Aureus specific medium 
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Fig 10 (iii): Culture plate with Pseudomonas Aeruginosa specific medium 
 
ANALYSIS OF PESTICIDES ORGANOCHLORINE, ORGANOPHOSPHORUS 
AND PYRETHROIDS: 
 
The results showed that there were no traces of pesticides residues such as Organo 
chlorine and Organo phosphorus Pesticides in the sample PPC. Further sample shows the 
presence of Cypermethrin belongs to pyrethroid type of pesticide at the concentration of 0.1 
mg/kg which was low when compare the AYUSH prescribed limit of 1mg/kg. 
 
Table 15: Pesticide residue: 
 
Pesticide Residue Sample PPC AYUSH Limit (mg/kg) 
I.Organo Chlorine Pesticides: 
Alpha BHC BQL 0.1 
Beta BHC BQL 0.1 
Gamma BHC BQL 0.1 
Delta BHC BQL 0.1 
DDT BQL 1 
Endosulphan BQL 3 
II.Organo Phosphorus 
Pesticides: 
  
Malathion BQL 1 
Chlorpyriphos BQL 0.2 
Dichlorovos BQL 1 
III.Pyrethroid:   
Cypermethrin 0.1 mg/kg 1 
 
BQL – Below quantification limit 
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AFLOTOXIN ASSAY BY TLC (B1,B2,G1,G2): 
 
The results shown that there is a presence of aflatoxins B1 in the sample PPC and 
further there is no detection other aflatoxins like aflatoxins B2, G1 and G2 when compare to 
that of the respective standards. 
Table 16: Aflatoxin assay: 
 
Aflatoxin Sample PPC AYUSH Specification limit 
B1 Present – 0.01 ppm level 0.5 ppm 
B2 Not Detected - Absent 0.1 ppm 
G1 Not Detected - Absent 0.5 ppm 
G2 Not Detected - Absent 0.1 ppm 
 
BIOCHEMICAL ANALYSIS OF PARANGIPATTAI CHOORANAM: 
 
I Results of Acid radicals studies: [Table 17 (i)] 
S.NO Parameter Observation Result 
1 Test for Sulphate Cloudy appearancePresent Positive 
2 Test for Chloride - Negative 
3 Test For Phosphate - Negative 
4 Test For Carbonate   Cloudy appearancePresent Positive 
5 Test For Nitrate - Negative 
6 Test for Sulphide - Negative 
7 Test For Fluoride &oxalate - Negative 
8 Test For Nitrite - Negative 
9 Test For Borax - Negative 
 
Interpretation 
  The acidic radicals test shows the presence of Sulphate and Carbonate. 
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II Results of basic radicals studies:[Table 17 (ii)] 
 
S.NO Parameter Observation Result 
1  Test for Lead  - Negative 
2 Test for Copper - Negative 
3 Test For Aluminium - Negative 
4 Test For Iron Mild red colour appear Positive 
5 Test For Zinc White precipitate is 
formed 
Positive 
6 Test for Calcium Cloudy appearance and 
white precipitate  present 
Positive 
7 Test For Magnesium - Negative 
8 Test For Ammonium Brown colour appear Positive 
9 Test For Potassium Yellow precipitate is 
obtained 
Positive 
10 Test For Sodium - Negative 
11 Test For Mercury - Negative 
12 Test For Arsenic - Negative 
 
Interpretation 
 The basic radical test shows the presence ofIron, Zinc,Calcium,Ammonium, 
Potassiumand absence of heavy metals such as lead, arsenic and mercury. 
 
III Test for Phytochemical:[Table 17 (iii)] 
S.NO Parameter Observation Result 
1 Test for Starch Blue colour developed [Fig 11 (i)] Positive 
2 Test for Reducing sugars Characteristic coloured precipitate present 
[(Fig 11 (ii)] 
Positive 
3 Test For Alkaloids Yellow colour developed[Fig 11 (iii)] Positive 
4 Test For Tannic acid. Blue-black precipitate obtained[Fig 11 (iv)] Positive 
6 Test for Amino acid - Negative 
7 Test for Flavonoids  Yellow colour appear [Fig 11 (v)] Positive 
8 Test for Glycosides 
(Borntrager‘s test) 
Pink colour appear [Fig 11 (vi)] Negative 
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9 Test for Steroids Yellow with green fluorescence present 
[Fig 11 (vii)] 
Positive 
10 Test for Triterpenoids 
(Liebermann–Burchard 
test) 
Red ring appear [Fig 11 (viii)] Positive 
11 Test for Coumarin Yellow colour formed [Fig 11 (ix)] Positive 
12 Test for Saponins Copious lather formed [Fig 11 (x)] Positive 
13 Test for Anthrocyanin Bluish green colour formed [Fig 11 (xi)] Negative 
14 Test for phenol Bulky white precipitate formed [Fig 11 
(xii)] 
Positive 
 
Interpretation 
 The phytochemical test shows the presence of Starch, Sugar, Alkaloids, Tannic 
acid, Flavonoids, Steroids, Triterpenoids, Coumarin, Saponin and Phenol. 
 
 
 
Fig 11(i): Test for Proteins  Fig 11(ii): Test for carbohydrate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 11(iii): Test for Alkaloids      Fig 11(iv): Test for Tanins 
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Fig 11(v): Test for Flavinoids                            Fig 11(vi): Test for Glycosides 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 11(vii): Test for Steroids   Fig 11(viii): Test for Triterpenoids 
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Fig 11(ix):Test for Coumarin                           Fig 11(x): Test for Saponin 
 
 
 
    
 
Fig 11(xi): Test for Anthrocyanin                            Fig 11(xii): Test for Phenol  
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CLINICAL STUDIES 
 
30 children with the complaints of Venpulli (Vitiligo) were treated in Kuzhanthai 
Maruthuvam department of Ayothidas Pandithar hospital, National Institute of Siddha, 
Chennai with the trail drug Parangipattai chooranam and Annabedhi chenduram twice a day 
for 48 days. Results were observed under the following criteria. 
 
DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO SEX:  
 
Table 18(i): 
 
S.No Sex No. of cases Percentage (%) 
1 Male child 15 50 
2 Female child 15 50 
 
Fig 12(i): 
 
 
 
Inference: 
Out of 30 children 16 (53.3%) were female children and 14 (46.7%) were male 
children. 
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DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO AGE: 
 
Table 18(ii): 
 
S.No Age No. of cases Percentage (%) 
1 5-6 7 23.3 
2 7-8 7 23.3 
3 9-10 12 40 
4 11-12 4 13.3 
 
 
Fig 12(ii): 
 
 
 
Inference: 
 
 40% of the children were between 9 to 10 years of age, 23.3% of children were 
between 5 to 6 and 7 to 8 years of age and 13.30% of children were between 11 to 12 years 
of age. 
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DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO SOCIO 
ECONOMIC STATUS: 
 
Table 18(iii): 
S.No Socio economic status No. of cases Percentage (%) 
1 Upper 1 3 
2 Middle upper 11 37 
3 Middle lower 9 30 
4 Lower 9 30 
 
 
Fig 12(iii): 
 
 
 
Inference: 
According to parent‘s socio economic status, about 3% were under upper economic 
group, 37% were under middle upper economic status group, 30% were under middle lower 
economic status group and 30% were lower economic group status. 
 
 
 
0
5
10
15
20
25
30
35
40
Upper Middle upper Middle lower Lower
3
37
30 30
SOCIOECONOMIC STATUS
81 
 
DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO 
RELIGION: 
Table 18(iv): 
S.No Religion No. of cases Percentage (%) 
1 Hindu 26 87 
2 Christian 3 10 
3 Muslim 1 3 
 
 
Fig 12(iv): 
 
 
 
Inference: 
 
About 87% were Hindu, 10% were Christian and 3% were muslim. 
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DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO THINAI: 
 
Table 18(v): 
 
S.No Nilam No of cases Percentage (%) 
1 Kurinji 1 3 
2 Mullai - - 
3 Marutham 1 3 
4 Neithal 28 94 
5 Paalai - - 
 
 
Fig 12(v): 
 
 
 
Inference: 
 
About 94% of affected children were from Neithal nilam, 3% were from Marutham 
nilam and 3% were from Kurinji nilam. 
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DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO 
PARUVAKAALAM: 
 
Table 18(vi): 
 
S.No Paruvakaalam No. of cases Percentage (%) 
1. Karkaalam (Avani – puratasi) - - 
2. Koothirkaalam (Iyppasi – karthikai) 11 37 
3. Munpani (Markazhi – Thai) 10 33 
4. Pinpani (Masi – Panguni) 9 30 
5. Elavenil (Chitirai, Vaigasi) - - 
6. Mudhuvenil (Aani, Aadi) - - 
 
 
Fig 12(vi): 
 
 
 
Inference: 
According to paruvakaalam highest incident of 11 cases (37%) were noted in 
Koothirkaalam, 10 cases (33%) were noted in Munpanikaalam, 9 cases (30%) were noted in 
Pinpanikaalam.  
 
 
0%
5%
10%
15%
20%
25%
30%
35%
40%
0%
37%
33%
30%
0% 0%
PARUVAKAALAM
84 
 
DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO 
DERANGEMENT OF VATHAM: 
Table 18(vii): 
S.No Classification of Vatham No. of Cases Percentage (%) 
1. Pranan 1 3 
2. Abanan 1 3 
3. Viyanan 30 100 
4. Uthanan - - 
5. Samanan 30 100 
6. Naagan - - 
7. Koorman - - 
8. Kirukaran - - 
9. Devadhathan - - 
10. Dhananjeyan - - 
 
Fig 12(vii): 
 
 
Inference: 
According to Vatham, derangement of Viyanan and Samanan was noted in 30 
children (100%), derangement of Pranan in 1 child (3%), and derangement of Abanan in 1 
child (3%). 
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DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO 
DERANGEMENT OF PITHAM: 
 
Table 18(viii): 
 
 
Fig 12(viii): 
 
 
 
Inference: 
According to Pitham, derangement of Prasagam and Saathagam was seen in 30 
children (100%). 
  
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Analapitham Ranjagam Saathagam Prasagam Alosagam
0% 0%
100% 100%
0%
PITHAM
S.No Types of Pitham No.of Cases Percentage (%) 
1. Analapitham - - 
2. Ranjagam - - 
3. Saathagam 30 100 
4. Prasagam 30 100 
5. Alosagam - - 
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DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO 
DERANGEMENT OF EZHU UDARKATTUGAL: 
 
Table 18(ix): 
S.No Udarkattugal No.of Cases Percentage (%) 
1. Saaram 30 100 
2. Senneer 30 100 
3. Oon - - 
4. Kozhuppu - - 
5. Enbu - - 
6. Moolai - - 
7. Sukkilam/Suronitham - - 
 
Fig 12(ix): 
 
Inference: 
According to Udarkattgal, derangement of Saaram and Senneer was seen in 100% of 
children.  
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DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO 
DERANGEMENT OF ENN VAGAI THERVUGAL: 
Table 18(x): 
S.No Enn Vagai Thervugal No.of Cases Percentage (%) 
1 Naa - - 
2 Niram 30 100 
3 Mozhi - - 
4 Vizhi - - 
5 Malam  - - 
6 Moothiram - - 
7 Sparisam - - 
8 Naadi Described below 
 
Fig 12(x): 
 
 
Inference: 
According to Envagai thervu, Niram is affected in all children. 
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DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO 
OBSERVATION OF NAADI: 
Table 18(xi): 
S.No Naadi No. of cases Percentage (%) 
1 Vaathapitham 5 17 
2 Pithavatham 23 77 
3 Kabapitham 2 6 
 
Fig 12(xi): 
 
Inference: 
According to Naadi most of the children had Pithavatha naadi (77%), 17 % had 
Vaathapitha naadi and 6% had Kabapitha naadi. 
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DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO 
OBSERVATION OF NEIKURI ANALYSIS: 
Table 18(xii): 
S.No Character of urine Neikuri Reference No.of Cases Percentage (%) 
1. Spreads like snake Vatha Neer 4 13 
2. Spreads like ring Pitha Neer 21 70 
3. Static as pearl Kaba Neer 5 17 
 
Fig 12(xii): 
 
Inference: 
According to Neikuri, Vatha neer was observed in 13% of cases, pitha neer was 
observed in 70% of cases, Kaba neer was observed in 17% of cases. 
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DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO 
OBSERVATION OF SITE OF LESION: 
Table 18(xiii): 
S.No Site of lesion No of cases Percentage (%) 
1 Hand 5 17 
2 Upper limb 7 23 
3 Trunk 9 30 
4 Lower limb 20 67 
5 Face / Neck 10 33 
6 Feet 4 13 
Fig 12(xiii): 
 
Inference: 
According to site of lesion, Out of 30, 5 children (17%) had lesion in hand region, 7 
children (23%) had lesion in upper limb, 9 children (30%) had lesion in trunk, 20 children 
(67%) had lesion in lower limb, 10 children (33%) had lesion in face / neck and 4 children 
(13%) had lesion in feet region. Out of 30 children some of them are affected in multiple 
sites. 
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DISTRIBUTION OF CHILDREN WITH VENPULLI ACCORDING TO 
OBSERVATION OF DURATION: 
Table 18(xiv): 
S.No Duration of disease No. of cases Percentage (%) 
1 1 – 6 months 4 13 
2 6 – 11 months 1 3 
3 1 – 2 years 10 33 
4 2.1 – 3 years 5 17 
5 3.1 – 4 years 5 17 
6 4.1 – 5 years 4 13 
7 6 to 8 years 1 3 
 
Fig 12(xiv): 
 
Inference: 
 According to duration of lesion, 13% of children had symptoms for a period of 1 – 6 
months, 3% had symptoms for 6 – 11 months, 33% had symptoms for 1 – 2 years, 17% had 
symptoms for 2.1 – 3 years, 17% had symptoms for 3.1 – 4 years, 13% had symptoms for 
4.1 – 5 years, 3% had symptoms for 6 – 8 years. 
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CASE REPORT OF CHILDREN BASED ON VASI SCORE: 
Table 18(xv): 
S.No OP No Age/sex `         VASI SCORE Clinical improvement 
Before 
treatment 
After 
treatment 
1 J53023 5/MC 2 2 Pigmented spots present 
2 J67723 11/MC 4 4 Pigmented spots present 
3 I95743 8/MC 8 8 Pigmented spots present 
4 J18389 9/FC 12 12 Pigmented spots present 
5 J53927 5/FC 6.75 6.75 Pigmented spots present 
6 I13367 12/MC 3.75 3 Good improvement 
7 I92679 9/FC 25.75 25.75 Pigmented spots present 
8 H79034 9/FC 4.5 4.5 Pigmented spots present 
9 J78338 9/MC 7 3 Good improvement 
10 J83578 10/FC 8.50 6.25 Pigmented spots present 
11 G06709 8/MC 1 0.75 Good improvement 
12 G38277 9/FC 5.25 5.25 Pigmented spots present 
13 J53478 5/MC 10 10 Pigmented spots present 
14 J79539 8/FC 1.75 1 Good improvement 
15 G14179 7/MC 5.25 5.25 Pigmented spots present 
16 I5508 6/FC 9 9 Pigmented spots present 
17 J69491 12/MC 2 2 Pigmented spots present 
18 I93488 10/FC 2.25 1.75 Good improvement 
19 H26903 8/MC 1.75 1.50 Good improvement 
20 I2673 9/MC 8 6.75 Good improvement 
21 I56568 9/MC 1.75 1.25 Good improvement 
22 I33170 5.6/FC 4.50 3 Good improvement 
23 J82400 9/FC 0.50 0.25 Good improvement 
24 K01039 12/MC 17.75 14.50 Good improvement 
25 K5516 6/FC 5 3.75 Good improvement 
26 H62701 9/FC 1.50 1 Good improvement 
27 I16607 6/FC 2 0.50 Good improvement 
28 J69637 8/MC 1 0.375 Good improvement 
29 H51422 10/FC 1 0.75 Good improvement 
30 K16822 8/MC 4 3 Good improvement 
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Fig 12(xv): 
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STATISTICAL ANALYSIS: 
 All collected data were entered into MS Excel software using different columns as 
variables and rows as patients, SPSS software was used to perform statistical analysis. Basic 
descriptive statistics include frequency distributions and cross-tabulations were performed. 
The quantity variables were expressed as Mean ± Standard Deviation and qualitative data as 
percentage. A probability value of <0.05 was considered to indicate as statistical 
significance. Paired ‗t‘  test was performed for determining the significance between before 
and after treatment. In my study statistical analysis was done for VASI score. 
Paired Sample Statistics: 
 VASI Score: 
Table 19: Distribution of Mean and Standard Deviation of VASI Score before and after 
treatment is as follows. 
VASI Score Mean ± Standard Deviation  t Value p Value 
Before treatment 5.58 ± 5.4  
3.79 
 
P < 0.001 
After treatment 4.89 ± 5.36 
 
The Mean Standard Deviation of VASI Score before and after treatment was 5.58 ± 
5.4 and 4.89 ± 5.36 respectively which is statistically significant (p < 0.001).  
The analysis reveals that there is 12% reduction in depigmentation when compared 
to before treatment. 
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PHOTOGRAPHS OF PATIENTS BEFORE AND AFTER TREATMENT: 
    
     Fig 13 (i): Before treatment 
 
 
    
 
Fig 13 (ii): After treatment 
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Fig 14 (i): Before treatment 
 
 
 
   Fig 14 (ii): After treatment 
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Fig 15 (i): Before treatment 
 
 
Fig 15 (ii): After treatment 
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   Fig 16 (i): Before treatment 
 
 
 
 
 
 Fig 16 (ii): After treatment 
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DISCUSSION 
 AProtocol was prepared and submitted before Institutional Ethical Committee 
(IEC)ofNationalInstituteofSiddha. 
 The trial was registered in Clinical trial Registry of India 
 The trial drug “PARANGIPATTAI CHOORANAM (internal) and ANNABEDHI 
CHENDURAM (external)” was given for 48 days. For OP patients before and after 
treatment the clinical assessment is done and prognosis was noted. 
 
PRECLINICAL STUDIES 
 Physicochemical analysis: 
The drug Parangipattai choornam was in the consistency of fine powder with pale 
milky white in colour with mild odour, bitter and slightly sweet in taste.Microscopic 
observation of the particle size analysis reveals that the average particle size of the sample 
PPC was found to be 121.9± 45.24 µm further the sample PPC has particle with the size 
range of lowest 41.1 µm to highest 211.341.1 µm. 
 
Physico-chemical analysis was done as preliminary evalution of Parangipattai 
chooranam. The method of measuring the moisture content in solid materials is loss on 
drying (LOD). Low moisture content is always desirable for higher stability of drugs. In 
Parangipattai chooranam loss of drying at 105C
0
 was found to be 8.5%, it falls in between 
the limit range (1-20%). So the less moisture content shows the good stability of the drug 
Parangipattai chooranam. 
 
 The ash value represents the purity of the drugs.The total ash includes both 
physiological ash, which is derived from the organic matter, and non-physiological ash 
which is the residue of the extraneous matters like sand/soil, inorganic materials. The non-
physiologic ash is represented by acid soluble ash .The total ash in Parangipattai chooranam 
found to be 0.55% and the acid insoluble ash to be 0.32%. The both ash value were within 
the normal range. The minimal level of acid insoluble ash shows the less inorganic residue 
and purity of the Parangipattai chooranam. 
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 The extractive values help to indicate the nature of chemical constituents present in 
the drug. The water soluble substance is polar in nature and the alcohol has the ability to 
dissolve non-polar substance.The water soluble extract value of Parangipattai chooranam is 
28.55% and the Alcohol soluble extractive is 34.44%. Itshows the possibility of water 
soluble constituents such as sugars, plant acids, mucilageand alcohol soluble substance such 
as tannins, resinsand alkaloids to be present in the drug.  
 
 Strongly acidic nature of the drug can cause harmful effects to the body. So the 
screening for the pH is important for the drug.It represents the chemical nature of the drug. 
The pH of Parangipattai chooranam is found to be 4.8 that is weakly acidic and safe in pH. 
The weakly acidic drugs are rapidly absorbed from stomach. So the trial drug Parangipattai 
chooranam can act rapidly on oral administration. 
  
 Rf value of the peaks ranges from 0.30 to 0.89.  Further the peak 2 occupies the 
major percentage of area of 38.78 % which denotes the abundant existence of such 
compound. Followed by this peak 3 and 1 occupies the percentage area of 31.34 and 
16.90%. Peak 4 occupies the percentage area of 13%. 
 
 The drug is free of microbial contamination and pesticide residues. In heavy metals 
analysis mercury was not detected and lead, arsenic, cadmium were present within the 
permissible limit.Aflatoxin like B2, G1, G2 were not detected except B1 which was within 
the permissible limit. 
 
 Biochemical analysis 
The Bio chemical analysis of trial medicines showed shows presence ofSulphate, 
Carbonate, Iron, Zinc, Calcium, Ammonium and Potassium.  
Phytochemicals such as Starch, Sugar, Alkaloids, Tannic acid, flavonoids, steroids, 
triterpenoids, coumarin, saponins and phenol are present in the trial drug 
CLINICAL STUDIES: 
 SEX:  
In the present study, Out of 30 cases 50% were male child and 50% were female 
child.  
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 AGE: 
In this study most of them were under 9 – 10 year of age (40%). 
 
 SOCIOECONOMIC STATUS:  
Middle economic status (67%) group of peoples are mostly affected. 
 
 THINAI: 
 According to this study high incidence in Neithal nilam (94%) may be due to the 
location of study centre (i.e,) Neithal. 
 
 PARUVAKAALAM:  
According to Paruvakalam high incidence of cases 37% were reported in Koothir 
kaalam and 33% were reported in Munpani kaalam and 30% were reported in 
Pinpani kaalam. 
 
 VATHAM:  
100% of cases were affected from Viyanan and Samanan. Viyanan is affected due to 
change in skin colour and Samanan is affected because it doesn‘t control the other 
vadhas.  
 
 PITHAM:  
According to Pitham, Prasagam and Saathagam were affected in 100% of cases.  
 Prasagam is important for pigmentation of skin and it was affected due to 
hypopigmention of the skin. 
 Saathagam was affected as Venpulli was a cosmetic issue that make the 
children to deny the exposure to the environment. 
 
 UDARKATTUGAL: 
Among the treated childrenSaaram and Senneer was affected in 100% of cases. 
 Saaram strengthens the body and mind. It was affected in Venpulli due to 
mental disturbances and depression caused by hypopigmentation. 
 Senner is responsible for boldness and complexion in a person which was 
affected in Venpulli, due to hypopigmentation of skin causing inferiority that 
affects self-confidence of the child. 
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 ENN VAGAI THERVU: 
Niram is affected in 100% of cases which shows depigmented skin in all chidren. 
 
 NAADI: 
On examination of naadi, 77% of cases had Pithavatha naadi, 13% of cases had 
Vaathapitha naadi and 6% of cases had Kabapitha naadi. 
 
 NEIKURI: 
 On Neikuri examination 13% were having vatha neer, 70% were having pitha neer and 
17% were having kabha neer. 
 
 SITE OF LESION:  
According to site of lesion, 17% had lesion in hand region,23% had lesion in upper limb, 
30%had lesion in trunk, 67% had lesion in lower limb, 33%had lesion in face / neck and 
13% had lesion in feet region. Out of 30 children some of them were affected from 
multiple sites. 
 
CLINICAL IMPROVEMENT: 
 
 100% of children had pigmentation spots in depigmented area and in 57% of cases had 
good improvement as per VASI score. 
 The Mean Standard Deviation of VASI Score before and after treatment was 5.58 ± 5.4 
and 4.89 ± 5.36 respectively which is statistically significant (p < 0.001).  
 The analysis reveals that there is 12% reduction in depigmentation when compared to 
before treatment. 
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SUMMARY 
 
 Evaluation of Parangipattai chooranam (Internal) and Annabedhi chenduram 
(External) was done after getting approved by IEC of National Institute of Siddha. 
[IEC No: NIS/IEC/2016/11-24/14.10.2016] and the trial is registered in Clinical trial 
Registry of India with Reg.NoCTRI/2017/06/008755 [Registered on: 05/06/2017]. 
 The raw drugs of Parangipattai chooranam and Annabedhi chenduram were 
identified and authentication certificate was obtained.    
 The drug Parangipattai choornam was a fine powder pale milky white in colour with 
mild odour, bitter and slightly sweet in taste. 
 The drug size has a particlesize with the range of lowest 41.1 µm to highest 
211.341.1 µm. The loss on drying indicates the moisture content of the drug was 
determined as 8.5 ± 2.8%. The total ash was found to be 0.55 ± 0.05% which 
indicates the inorganic content of the drug. The water soluble ash was calculated as 
7.46 ± 0.72% and the value of acid insoluble ash was found to be 0.32 ± 0.15% 
which indicates that the drug contains negligible amount of siliceous matter. The 
water soluble extractive value and alcohol soluble extractive value were found to be 
25.86 ± 0.81% and 34.44 ± 2.12%. The pH value is measured as 4.8 which indicate 
that the drug is acidic.  
 HPTLC was done to identify phyto- chemicals and their Rf values were calculated.  
 The drug is free of microbial contamination and pesticide residues.  
 In heavy metals analysis mercury was not detected and lead, arsenic, cadmium were 
present within the permissible limit. 
 Aflatoxin like B2, G1, G2 were not detected except B1 which was within the 
permissible limit. 
 The disease Venpulli was taken for the clinical study with Parangipattai chooranam 
(Internal) and Annabedhi chenduram (External) as a trial medicine and 30 cases 
were selected based on the approved protocol.  
 The detailed study of Venpulli with reference to its etiology, pathogenesis, 
investigations, clinical features, diagnosis and treatment with trial drug was done. 
 The results were observed by VASI score. Among the 30 cases treated 57% of the 
cases had moderate improvement and 43% had pigmented spots in depigmented 
area. 
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 Statistical analysis: The Mean Standard Deviation of VASI Score before and after 
treatment was 5.58 ± 5.4 and 4.89 ± 5.36 respectively which is statistically 
significant (p < 0.001).  
 The analysis reveals that there is 12% reduction in depigmentation when compared 
to before treatment. 
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CONCLUSION 
 
 The poly herbal formulation Parangipattai chooranam (Internal) and Annabedhi 
chenduram (External)exhibited no toxicity on short term administration in children.   
 The present clinical study confirms the efficacy and safety of the trial drug 
―Parangipattai chooranam (Internal) and Annabedhi chenduram (External)‖ which is 
Siddha poly herbal and herbomineral formulation respectively.  
 It was found to be having good result on Venpulli patients in reducing clinical 
symptoms like depigmention of skin.  
 The Mean Standard Deviation of VASI Score before and after treatment was 5.58 ± 
5.4 and 4.89 ± 5.36 respectively which is statistically significant (p < 0.001). The 
analysis reveals that there is 12% reduction in depigmentation when compared to 
before treatment. 
 The qualitative outcome shows that 100% of the cases had pigmentation in 
depigmented area and good improvement in 57%. 
 From the above results, the trial drug ―Parangipattai chooranam (Internal) and 
Annabedhi chenduram (External)‖ provides moderate improvement in the treatment 
of Venpulli.  
 The open clinical trial conducted on Venpulli with the trial drug Parangipattai 
chooranam (Internal) and Annabedhi chenduram (External) creates a very good 
impact on the pigmentation of the affected area. Hence the author recommends by 
increasing the trial period for about 90 days will bring out the tremendous effect of 
the drug in future which will reduce the stress of the affected children and enable to 
lead a healthy life. 
 As a conclusion it can be stated that the Siddha Herbal formulation Parangipattai 
chooranam (Internal) and Annabedhi chenduram (External) can be used as a safe 
and extremely efficacious drug towards the management of Venpulli in children 
which takes a huge toll of inducing psychological stress and impact on the cosmetic 
purposes. 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF PARANGIPATTAI CHOORANAM (INTERNAL) 
AND ANNABEDHI CHENDURAM (EXTERNAL) FOR VENPULLI (VITILIGO) 
IN CHILDREN. 
FORM 1- SCREENING PROFOMA 
1.  Sl no:    2. OP/ IP No:                           3.Name:          
4.  Age:    5.Gender:   6.Date of Enrollment:   
7.  Date of completion:     8.Informant:  
INCLUSION CRETERIA:                                      YES       NO 
 Age: Between 5 to 12 years  
 Sex: Both male and female children 
 
 Hypo pigmented patches withHyper pigmented border   
without any structural changes in any part of the body 
 Patient‘s informant / Parent willing to sign the 
informed consent stating that he/she will  
consciously stick to the treatment during 48 days  
 
 Willing to cooperate for taking photographs  
whenever required with his\her consent  
 
EXCLUSION CRITERIA            YES           NO 
 Albinism  
 Dermatogical manifestations of Leprosy 
 Tinea versicolor 
 Burn scars 
 Dermatological aspect of Addisons diseases 
 Post inflammatory hypopigmentation 
 Pityriasis alba 
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 Alopecia aerate 
 Fungal infestation 
PATIENT SELECTED FOR TRIAL     
IF YES ADMITTED IN IP  
 
Signature of Investigator     :                                                      Signature ofGuide:     
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF PARANGIPATTAI CHOORANAM (INTERNAL) 
AND ANNABEDHI CHENDURAM (EXTERNAL) FOR VENPULLI (VITILIGO) IN 
CHILDREN. 
FORM II - CONSENT FORM  
CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the parent/guardian 
Signature  _________________ 
Date   _________________ 
Name  ________ _________ 
CONSENT BY PARENT 
 I have been informed to my satisfaction, by the attending physician, the purpose of 
the clinical trial, and the nature of drug treatment and follow-up to monitor and safeguard 
my son/daughter‘s body functions. 
 I am aware of my right to opt my son/daughter out of the trail at any time during the 
course of the trail without having to give the reasons for doing so. I agree to take 
photograph when and wherever required.  
I, exercising my free power of choice, hereby give my consent to include my son/daughter 
as a subject in the clinical trial entitled CLINICAL EVALUATION OF PARANGIPATTAI 
CHOORANAM (INTERNAL) AND ANNABEDHI CHENDURAM (EXTERNAL) FOR 
VENPULLI (VITILIGO). 
Date :      Signature  __________________ 
      Name   __________________ 
Place :      Signature of witness  __________________ 
      Name   __________________ 
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Njrpa rpj;j kUj;Jt epWtdk; 
mNahj;jpjhr gz;bjH kUj;Jtkid> nrd;id-47  
gl;lNkw;gbg;G Foe;ij kUj;Jtj;Jiw  
ntz;gil Neha;f;fhd gwq;fpg; gl;il #uzk; (cs;shl;rp) kw;Wk; md;dNgjp 
nre;Jhuk; (ntspahl;rp) gupfupg;Gj; jpwidf; fz;lwpAk; kUj;Jt Ma;T 
xg;Gjy; gbtk;  
Ma;thsuhy; rhd;wspf;fg;gl;lJ 
ehd; ,e;j kUj;Jt Ma;it Fwpj;;J midj;J tpguq;fisAk; Nehahspapd; ngw;NwhUf;F 
GhpAk; tifapy; vLj;Jiuj;Njd; vd cWjp mspf;fpNwd;. 
Njjp:        ifnahg;gk;: 
,lk;:         ngah;:  
Nehahspapd; ngw;Nwhh; xg;Gjy;  
 vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk;> kUe;jpd; jd;ik kw;Wk; kUj;Jt 
topKiwg; gw;wpAk;> ,e;j kUj;Jtj;ij njhlh;e;J vdJ Foe;ijapd; cly; ,af;fj;ijf; 
fz;fhzpf;fTk;> mjidg; ghJfhf;f gad;gLk; kUj;Jt Ma;Tfs; gw;wpAk; jpUg;;jp mspf;Fk; 
tifapy; Ma;T kUj;Jtuhy; tpsf;fpf; $wg;gl;lJ. 
ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; vg;nghOJ 
Ntz;LkhdYk; vd; Foe;ijia tpLtpj;Jf; nfhs;Sk; chpikia njhpe;jpUf;fpNwd;.  
ehd; vd;Dila Rje;jpukhf Njh;T nra;Ak; chpikiaf; nfhz;L ntz;gil  
Neha;f;fhd gwq;fpg; gl;il#uzk; (cs;shl;rp) kw;Wk;;md;dNgjp nre;Jhuk; 
(ntspahl;rp) ghpfhpg;Gj;jpwid fz;lwpAk; kUj;Jt Ma;Tf;F vdJ Foe;ijia cl;gLj;j 
xg;Gjy; mspf;fpNwd;. 
Njjp:         ngw;nwhh; ifnahg;gk;: 
,lk;:        ngaH: 
        rhl;rpf;fhuu; ifnahg;gk;: 
        ngau;:  
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF PARANGIPATTAI CHOORANAM (INTERNAL) 
AND ANNABEDHI CHENDURAM (EXTERNAL) FOR VENPULLI (VITILIGO) 
IN CHILDREN. 
     FORM II A - ASSENT FORM (By Patient) 
 
1. Sl.no:    2. OP/IP No:  3.Name: 
4.   Age :    5. Gender    :  6. Date of Enrollment: 
7.   Informant:    
 
  I, _________________________ understand that my parents (mom and 
dad)/ guardian have/ has given permission (said it's okay) for me to take part in the 
clinical trial about VENPULLI done by Dr.R.Vinodini. 
  I am taking part because I want to take part. I have been told that I can stop 
at any time if I want to do so and nothing will happen to me if I want to stop. I agree to 
take photograph when and wherever required. 
 
Date:      Signature of the patient: 
Place:      Signature of parent / guardian: 
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Njrpa rpj;j kUe;Jt epWtdk; 
mNahj;jpjhr gz;bjH kUj;Jtkid> nrd;id-47 
gl;lNkw;gbg;G Foe;ij kUj;Jtj;Jiw 
ntz;gil Neha;f;fhd gwq;fpg; gl;il #uzk; (cs;shl;rp) kw;Wk; md;dNgjp 
nre;Jhuk; (ntspahl;rp) gupfupg;Gj; jpwidf; fz;lwpAk; kUj;JtMa;T 
 
xg;Gjy; gbtk; Foe;ijf;fhdJ 
 -------------------------------- Mfpaehd; Njrpa rpj;j kUj;Jt epWtdj;jpy; gl;lNkw;gbg;G 
Foe;ij kUj;Jtj; Jiwapy; gapYk; kU.,uh.tpNdhjpdp mtu;fshy; elj;jg;gLk;; 
ntz;gil Neha;f;fhd gwq;fpg; gl;il #uzk; (cs;shl;rp) kw;Wk; md;dNgjp 
nre;Jhuk; (ntspahl;rp)ghpfhpg;Gj; jpwidf;; fz;lwpAk; kUj;Jt Ma;tpy; gq;Nfw;gjw;F 
vdJ ngw;NwhH\fhg;ghsu; jpU\jpUkjp---------------------------rk;kjk; njuptpj;jpUg;gij ed;F 
mwpNtd;.  
 vdf;F ,e;j Muha;r;rp gw;wp; GhpAk; tifapy; vLj;Jiuf;fg;gl;Ls;sJ. 
,t;thuha;r;rpapy; ,Ue;J vg;NghJ Ntz;LkhdhYk; tpyf vdf;F chpik ,Uf;fpd;wJ 
vd;gij gw;wpAk; ed;F njupe;Jnfhz;L ,e;j Muha;r;rpapy; gq;Nfw;f rk;kjpf;fpNwd;.  
Njjp:       Foe;ijapd; ifnahg;gk; 
,lk;:        ngah; 
       ngw;nwhh; ifnahg;gk; 
       ngaH 
 
  
112 
 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF PARANGIPATTAI CHOORANAM (INTERNAL) 
AND ANNABEDHI CHENDURAM (EXTERNAL) FOR VENPULLI (VITILIGO) IN 
CHILDREN. 
FORM III- CASE REPORT FORM 
Demographic data 
 Patient Id : OP/IP No. Visit Date : (__/__/____) 
Name :  
Age    :  
Gender: Male child         Female child Date Of Birth : (__/__/____) 
Father/ Mother /Guardian Name :  
 
Father‘s Occupation :  
 
Father‘s Monthly  Income :  
 
Religion : 
 
 
 
Socioeconomic Status : 
 
 
Patient Informant :  
 
 
Postal Address 
 
 
 Contact No : 
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1. COMPLAINTS AND DURATION 
------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------ 
2. HISTORY OF PRESENT ILLNESS  
------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------ 
 
3.  HISTORY OF PAST ILLNESS  
 
____________________________________________________________________ 
 
 FAMILY HISTORY 
 
Any Hereditary/ Familial Disease   Yes                      No 
If Yes, Details                                 --------------------------------------------------------------------  
Family H/O similar condition         -------------------------------------------------------------------- 
 
IMMUNIZATION HISTORY: 
 
 Immunization                    :  Complete           Incomplete         Complete but time lag 
 
FOOD HABITS: 
 
1. Veg  2. Non-Veg  3. Mixed 
General Examination 
1. Pallor    Yes     No 
2. Jaundice   Yes     No 
3. Cyanosis   Yes     No 
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4. Clubbing   Yes     No 
5. Pedal Edema   Yes     No 
6. Lymphadenopathy  Yes     No      
7. Jugular venous pulse  ___________ 
Vital signs:- 
1. Pulse rate                  - 
2. Heart rate                  - 
3. Respiratory Rate       - 
4. Temperature                  - 
Anthropometry:- 
          Height        -           cm 
          Weight        -           kg 
          EXAMINATION OF THE AFFECTED AREA: 
Site of the lesion             ------------------------------------ 
Color of the lesion         ------------------------------------- 
Size of the lesions          --------------------------------------- 
Shape of the lesions       --------------------------------------- 
Margin of the lesion       ---------------------------------------  
Other systems: 
Respiratory system  : Normal               Affected 
Cardio vascular system:  Normal               Affected 
Gastro intestinal system: Normal                Affected 
Musculoskeletal system: Normal          Affected 
Central nervous system: Normal                 Affected 
Endocrine system         : Normal                 Affected 
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SIDDHA ASSESSMENT: 
Nilam:-  
Kurinji  Mullai  Marutham      Neithal   Paalai 
Kaala Iyalbu:-  
 Kaarkalam    Koothirkaalam  Munpanikaalam  
 Pinpanikaalam              Illavenirkaalam              Muthuvenirkaalam 
Yaakai:- 
 Vatham          Vatha Pitham           Vatha Kabam 
 Pitham           Pitha vatham           Pitha Kabam 
 Kabam           Kaba Vatham           Kaba Pitham 
Gunam:-  
 Sathuvam   Rasatham   Thamasam 
Pori / Pulangal:- 
  Normal Affected  Remarks 
Mei / unarvu 
Vaai / suvai  
Kan / parvai  
Mooku / natram 
Sevi / olli 
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Kanmendhirium / Kanmavidayam 
       Normal     Affected  Remarks 
Kai / dhanam 
Kaal / ghamanam 
Vaai / vaaku 
Eruvai / visarkam 
Karuvai / anantham 
UYIR THATHUKKAL: 
Vatham:  Normal   Affected     Remarks 
Pranan  
Abanan 
Viyanan  
Uthanan 
Samanan 
Nagan  
Koorman 
Kirukaran  
Devathathan   
Dhanajeyan    
 
Pitham:  Normal Affected  Remarks 
Analam  
Ranjagam    
Saathagam   
Alosagam  
Prasagam 
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Kabam: 
   Normal Affected  Remarks 
Avalambagam    
Kilethagam   
Pothagam  
Tharpagam   
Santhigam  
UDALTHATHUKKAL: 
   Normal Affected  Remarks 
Saaram 
Senneer  
Oon  
Kozhuppu 
Enbu 
Moolai 
Sukilam / Suronitham   
ENVAGAI THERVUGAL: 
                            Normal  Affected  Remarks 
Naa  
 Niram 
 Thanmai 
 Suvai 
Niram   
Mozhi   
Vizhi  
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 Niram 
 Thanmai 
 Paarvai 
Sparisam  
Malam 
 Niram    
 Nurai    
 Elagal    
 Erugal    
 
Moothiram    Normal     Affected           Remarks 
 Neerkuri:       
Niram    
  Edai    
  Nurai   
  Manam  
  Enjal        
Neikuri: 
  Vatham  
  Pitham 
  Kabam 
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Others 
Naadi: 
 
Diagnosis: 
 
Date:       Signature of Investigator: 
 
Place:       Signature of Guide: 
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CLINICAL ASSESSMENT BY VITILIGO AREA SEVERITY INDEXES (VASI) 
SCORE: 
 
Sl.no Location     Hand units    Depigmentation      Total hand            
units 
  BT AT BT AT BT AT 
1. Hands       
2. Upper 
Extremities 
      
3. Trunk       
4. Lower 
Extremities 
      
5. Face/Neck       
6. Feet       
 Total       
 
TOTAL BODY VASI SCORE:  
Date:      Signature of Investigator: 
 
Place:        Signature of Guide: 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF PARANGIPATTAI CHOORANAM (INTERNAL) 
AND ANNABEDHI CHENDURAM (EXTERNAL) FOR VENPULLI (VITILIGO) 
IN CHILDREN. 
   FORM VI -DRUG COMPLIANCE FORM 
S. NO: ---------   OPD/IPD NO: --------------- NAME: -----------------------   
NAME OF THE DRUG:  Parangipattai Chooranam (Internal) & Annabedhi Chenduram 
(External)  
DOSAGE AND DURATION: 
INTERNAL:  ½ - 1 gram (bd) with Sakkarai for 48 days. 
  EXTERNAL: Apply with lemon juice in the affected area for 48 days  
DAY DATE MORNING NIGHT DAY DATE MORNING NIGHT 
1    25    
2    26    
3    27    
4    28    
5    29    
6    30    
7    31    
8    32    
9    33    
10    34    
11    35    
12    36    
13    37    
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14    38    
15    39    
16    40    
17    41    
18    42    
19    43    
20    44    
21    45    
22    46    
23    47    
24    48    
 
Date:                Signature of the Investigator: 
Station:      Signature of the Guide: 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF PARANGIPATTAI CHOORANAM (INTERNAL) 
AND ANNABEDHI CHENDURAM (EXTERNAL) FOR VENPULLI (VITILIGO) IN 
CHILDREN. 
FORM  V- DIETARY ADVICE FORM 
The following diet to be taken: 
 Drink adequate water 
 Green vegetables/spinach 
 Carrot 
 Watermelon 
 Coriander 
 Beetroot 
 Soya beans 
 Walnuts 
 Pumpkin 
 Apple 
 Fig fruit 
 Honey 
 Banana flower 
 Pomegranate 
 Black dates 
The following food should be avoided: 
 Bitter gourd                               
 Brinjal 
 Sea foods                       
 Pickles 
 Chicken   
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 Papaya 
 Chocolate                                  
 Green chilli 
 Tamarind      
 Citrus fruits (Grapes, Orange, Lemon) 
 Packaged food        
 Tinned foods or drinks 
 Curd      
 Raw tomato     
 Coffee 
 Raw garlic     
 Raw onion         
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF PARANGIPATTAI CHOORANAM (INTERNAL) 
AND ANNABEDHI CHENDURAM (EXTERNAL) FOR VENPULLI (VITILIGO) IN 
CHILDREN. 
FORM IV – PATIENT INFORMATION SHEET 
Name of Principal Investigator:-  Dr.R.VINODINI 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
     CLINICAL TRIAL. 
I, Dr.R.VINODINI Studying as PG Scholar in department of Kuzhandhai 
Maruthuvam at National Institute of Siddha, Tambaram Sanatorium doing a trial on the 
study VENPULLI (Vitiligo). Vitiligo is a disease, which is characterized by depigmentation 
of skin due to disappearance of melanocytes and melanin. In this regard, I am in a need to 
ask you few questions about your child illness. I will maintain confidentiality of your 
comments and data obtained. There will be no risk of disclosing your identity and no 
physical, psychological or professional risk is involved by taking part in this study. Taking 
part in this study is voluntary. No compensation will be paid to you for taking part in this 
study. 
           You can choose not to take part. However, taking part in the study may be of benefit 
to the community, as it may help us to understand the problem of defaulters and potential 
solutions. 
             If you agree your child to be a participant in this study, he/she will be included in 
the study primarily by signing the consent form and then you will be given the internal 
medicine PARANGIPATTAI CHOORANAM ½-1gm twice a day with palm jaggery and 
ANNABEDHI CHENDURAM as external medicine for 48 days. 
The information I am collecting in this study will remain between you and me.  
 If you wish to find out more about this study before taking part, you can ask all the 
questions you want to principle investigator Dr.R.VINODINI (9791979749). You can also 
contact the Member-secretary of Ethics committee, National Institute Siddha, Chennai 
600047, Tel no: 91-44-22380789, for rights and participation in the study.  
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Njrpa rpj;j kUe;Jt epWtdk; 
mNahj;jpjhr gz;bjH kUj;Jtkid> nrd;id-47 
 gl;lNkw;gbg;G Foe;ij kUj;Jtj;Jiw  
ntz;gil Neha;f;fhd gwq;fpg; gl;il #uzk; (cs;shl;rp) kw;Wk; md;dNgjp 
nre;Jhuk; (ntspahl;rp) gupfupg;Gj; jpwidf; fz;lwpAk; kUj;JtMa;T 
Muha;r;rpahsH ngah;: kU.,uh.tpNdhjpdp 
kUj;Jt Ma;tpw;fhd jfty; gbtk; 
 Njrpa rpj;j kUj;Jt epWtdj;jpy; Foe;ij kUj;Jtj; Jiwapy; gl;;l Nkw;gbg;G 
gapd;W tUk; kU.,uh.tpNdhjpdpMfpa ehd;; ntz;gil Neha;f;fhd gwq;fpg; gl;il 
#uzk; (cs;shl;rp) kw;Wk; md;dNgjp nre;Jhuk; (ntspahl;rp)ghpfhpg;Gj; jpwidf;; 
fz;lwpAk; kUj;Jt Muha;r;rpapy; <Lgl;Ls;Nsd;. ntz;gilvd;Dk; Nehapy; clypy; kq;fpa 
ntz;ikahd epwKs;s gy msthd Gs;spfSk;;> gilfSk;; tpfhukhff; fhZtNjhL 
rpyNtis mt;tplj;jpYs;s kapUk; ntSj;Jf; fhZk;;. .rpj;j kUe;Jt gl;lNkw;gbg;gpy; 
Ma;tpd; XU gFjpahf ntz;gil Neha;f;fhd gwq;fpg; gl;il #uzk; (cs;shl;rp) 
kw;Wk; md;dNgjp nre;Jhuk; (ntspahl;rp)ghpfhpg;Gj; jpwid fz;lwpAk; Ma;tpid 
Nkw;nfhz;Ls;Nsd;. 
     ,J rk;ge;jkhd Foe;ijapd; midj;J tptuq;fSk; ,ufrpakhf itf;fg;gLk; vd 
cWjp mspf;fpNwd;. ,J Nghd;w tptuq;fis njuptpg;gjhy; jq;fSf;Nfh jq;fsJ 
Foe;ijf;Nfh jq;fspd; Ntiy jsj;jpNyh ve;j XU ghjpg;Gk; Vw;glhJ. ,jpy; gazg;gb 
Kjypa ve;j cjtpj; njhifAk; toq;fg;gl khl;lhJ.,e;j Muha;r;rpf;F Nehapduhf Nru;e;j 
gpwF cq;fSf;F tpUg;gk; ,y;iynadpy; vg;NghJ Ntz;LkhdhYk; jq;fsJ Foe;ijia 
tpyf;fpf; nfhs;syhk;. ,Ue;jhYk; ,e;j kUj;Jt Ma;tpy; Nrh;tjd; %ykhf jq;fsJ 
Foe;ijapd; Neha; FiwtJ kl;Lky;yhky; kUj;Jtj;Jiw rhHe;j ty;YeHfSf;F ,e;j 
Neha;f;fhd jPh;Tfis fz;lwptjw;F kpfTk; cjtpahf ,Uf;Fk;. 
,e;j Muha;r;rpf;F jq;fsJ tpUg;gj;jpd; Ngupy; jq;fsJ Foe;ijia cl;gLj;Jk; 
gl;rj;jpy; Kjd;ikahf xg;Gjy; gbtj;jpy; ifnaOj;jpl;l gpd;G jhq;fs; gwq;fpg; gl;il 
#uzk; ; ½ - 1fp msT 2 Ntis gidnty;yj;jpy; 48 ehl;fs; cs;kUe;jhf ju Ntz;Lk; 
kw;Wk; md;dNgjp nre;Jhuk; xU Ntis vYkpr;ir rhw;wpy; fye;J ghjpf;fg;gl;l ,lj;jpy; 
G+r Ntz;Lk;. 
,e;j kUj;Jt Ma;tpd; njhlHghf cq;fsplkpUe;J Nrfupf;fg;gLk; midj;J 
tptuq;fSk; cq;fSf;Fk; Muha;r;rpahsuhd vdf;Fk; kl;LNk mwpe;jpUf;ff; $bajhf 
,Uf;Fk;.,e;j Muha;r;rp rk;ke;jkhf kw;w tpguq;fisAk; Nehapd; jd;ik gw;wpAk; mwptjw;F 
Muha;r;rpahsuhd kU.,uh.tpNdhjpdp ifNgrp vz; 9791979749 njhlu;G nfhs;syhk;. NkYk; 
,e;j Muha;r;rp njhlu;ghf epWtd ePjp newp FO Njrpa rpj;j kUe;Jt epWtdk; 
njhiyNgrp vz;  91-44-22380789 njhlu;G nfhs;syhk;. 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF PARANGIPATTAI CHOORANAM (INTERNAL) 
AND ANNABEDHI CHENDURAM (EXTERNAL) FOR VENPULLI (VITILIGO) IN 
CHILDREN. 
   Form VII – ADVERSE REACTION FORM   
1. Sl. No: 2. OP/ IP No  : 3. Name: 
4. Age: 5. Gender: 6. Date of Enrollment: 
7. Date of completion:  8. Informant: 
 
 
Name       : 
Age       : 
Gender    : 
OPD/ IPD No    : 
Date of trial commencement  : 
Date of withdrawal from trial   : 
Description of adverse reaction  : 
 
 
Date:        Signature of Investigator: 
Place:           
          Signature of Guide: 
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                                        NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF PARANGIPATTAI CHOORANAM (INTERNAL) 
AND ANNABEDHI CHENDURAM (EXTERNAL) FOR VENPULLI (VITILIGO) IN 
CHILDREN. 
 FORMVIII - WITHDRAWL FORM 
1.  S.I  No:    2. OP/ IP No:                           3.Name:                                                   
4.Age:    5.Gender:   6.Date of Enrollment:   
7.  Date of completion:     8.Informant:   
 
Date of trial commencement    : 
Date of withdrawal from trial   : 
Reason(s) for withdrawal   : Yes/ No  
Long absence at reporting   : Yes/ No 
Irregular treatment     : Yes/ No 
Shift of locality      : Yes/ No 
Complication / adverse reactions if any : Yes/ No 
Exacerbation of symptoms   : Yes/ No 
 Patient not willing to continue  : Yes/ No 
 
Date:       Signature of Investigator: 
Place:       Signature of Guide: 
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NATIONAL PHARMACOVIGILANCE PROGRAMME FOR SIDDHA DRUGS 
 
 
 
 
Please note:  i.Allconsumers / patients and reporters information will remain confidential. 
ii. It is requested to report all suspected reactions to the concerned, even if it does 
not have complete data, as soon as possible. 
PeripheralCenter code:     State:  
1. Patient / consumer identification (please complete or tick boxes below as appropriate) 
 
Name  Father name 
 
Patient / Record No. 
Ethnicity  Occupation 
Address  
Village / Town 
Post / Via 
District / State    
Date of Birth / Age: 
 
Sex:     Male / Female  
Weight : 
Degam: 
 
2. Description of the suspected Adverse Reactions (please complete boxes below) 
 
Date and time  of initial 
observation 
 Season: 
Description of reaction   
 
 Geographical area: 
 
 
 
 
 
Reporting Form for Suspected Adverse Reactions to Siddha Drugs 
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3. List of all medicines / Formulations including drugs of other systems used by the patient 
during the reporting period: 
Medicine Daily 
dose 
Route of 
administration 
& Vehicle - 
Adjuvant 
Date  Diagnosis for which 
medicine taken  
Starting Stopped 
Siddha 
 
 
 
 
     
Any other system 
of medicines 
 
 
     
 
4. Brief details of the Siddha Medicine which seems to be toxic : 
 
Details Drug – 1 Drug – 2 Drug – 3 
a) Name of the medicine    
b) Manufacturing unit and batch 
No. and date 
   
c) Expiry date    
d) Purchased and obtained from    
e) Composition of the 
formulation / Part of the drug 
used 
   
 
b) Dietary Restrictions if any 
c) Whether the drug is consumed under Institutionally qualified medical supervision or used as self-
medication.  
d) Any other relevant information. 
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5. Treatment provided for adverse reaction: 
 
6. The result of the adverse reaction / side effect / untoward effects (please complete the boxes 
below) 
 
Recovered:           Not 
recovered: 
 Unknown: Fatal: If Fatal 
Date of death: 
Severe:   Yes   /   No. Reaction abated after drug stopped or dose reduced: 
 
Reaction reappeared after re introduction: 
 
 
Was the patient admitted to hospital? If yes, 
give name and address of hospital 
 
 
7. Any laboratory investigations done to evaluate other possibilities?  If Yes specify:  
 
8. Whether the patient is suffering with any chronic disorders? 
Hepatic    Renal    Cardiac    Diabetes    Malnutrition  
Any Others  
9. H/O previous allergies / Drug reactions:  
 
10. Other illness (please describe): 
 
11. Identification of the reporter: 
 
Type (please tick):  Nurse / Doctor / Pharmacist / Health worker / Patient / Attendant / Manufacturer 
/                                                                      
                                Distributor / Supplier / Any others (please specify) 
Name: 
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Address: 
 
Telephone / E – mail if any : 
 
 
Signature of the reporter:       Date: 
 
Please send the completed form to:  
     The Director 
          National Institute of Siddha, 
(Pharmacovigilance Regional   Centre For Siddha Medicine), 
     Tambaram Sanatorium, Chennai-600 047. 
      (O) 044-22381314 Fax : 044 – 22381314 
         Website : www.nischennai.org 
 Email: nischennaisiddha@yahoo.co.in 
This filled-in ADR report may be sent within one month 
of observation /occurrence of ADR   
Date:      
Station: 
Signature of the Investigator: 
Signature of the Guide:  
Name & address of the 
RRC-ASU / PPC-ASU 
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CTRI Number CTRI/2017/06/008755 [Registered on: 05/06/2017] - Trial Registered Prospectively
Last Modified On 25/05/2017
Post Graduate Thesis Yes
Type of Trial Interventional
Type of Study Siddha
Study Design Single Arm Trial
Public Title of Study Clinical evaluation of Venpulli (Vitiligo) in children
Scientific Title of
Study
Clinical Evaluation of PARANGIPATTAI CHOORANAM (Internal medicine) and ANNABEDHI
CHENDURAM (External medicine) for VENPULLI (Vitiligo) in children
Secondary IDs if Any Secondary ID Identifier
NIL NIL
Details of Principal
Investigator or overall
Trial Coordinator
(multi-center study)
Details of Principal Investigator
Name Dr R Vinodini
Designation MD siddha
Affiliation National institute of siddha
Address Department of Kuzhanthai maruthuvam, Ayothidass pandithar
hospital, National institute of siddha, Tambaram sanatorium,
Chennai Department of Kuzhanthai maruthuvam, Ayothidass
pandithar hospital, National institute of siddha, Tambaram
sanatorium, Chennai
Kancheepuram
TAMIL NADU
600047
India
Phone 9791979749
Fax
Email vinodini02@gmail.com
Details Contact
Person (Scientific
Query)
Details Contact Person (Scientific Query)
Name Dr M Meenakshi sundaram
Designation Head of the department
Affiliation National institute of siddha
Address Department of Kuzhanthai maruthuvam, Ayothidass pandithar
hospital, National institute of siddha, Tambaram sanatorium,
Chennai Department of Kuzhanthai maruthuvam, Ayothidass
pandithar hospital, National institute of siddha, Tambaram
sanatorium, Chennai
Kancheepuram
TAMIL NADU
600047
India
Phone 9444214582
Fax
Email mmssiddha@gmail.com
Details Contact
Person (Public Query)
Details Contact Person (Public Query)
Name Dr A M Amala Hazel
Designation Lecturer
Affiliation National institute of siddha
Address Department of Kuzhanthai maruthuvam, Ayothidass pandithar
hospital, National institute of siddha, Tambaram sanatorium,
page 1 / 3
REF/2017/01/013048
CTRI Website URL - http://ctri.nic.in
Chennai Department of Kuzhanthai maruthuvam, Ayothidass
pandithar hospital, National institute of siddha, Tambaram
sanatorium, Chennai
Kancheepuram
TAMIL NADU
600047
India
Phone 9486909809
Fax
Email dramalaaruldhas@gmail.com
Source of Monetary or
Material Support
Source of Monetary or Material Support
> Self
Primary Sponsor Primary Sponsor Details
Name Self
Address National institute of siddha, Tambaram sanatorium, chennai
Type of Sponsor Other [Research student]
Details of Secondary
Sponsor
Name Address
NIL NIL
Countries of
Recruitment
List of Countries
India
Sites of Study Name of Principal
Investigator 
Name of Site Site Address Phone/Fax/Email
Dr R Vinodini National institute of
siddha
Department of
Kuzhanthai
maruthuvam,
Ayothidass pandithar
hospital, National
institute of siddha,
Tambaram sanatorium,
Chennaittt
Kancheepuram
TAMIL NADU
9791979749
vinodini02@gmail.com
Details of Ethics
Committee
Name of Committee Approval Status Date of Approval Is Independent Ethics
Committee?
Institutional ethics
committee
Approved 14/10/2016 No
Regulatory Clearance
Status from DCGI
Status Date
Not Applicable No Date Specified
Health Condition /
Problems Studied
Health Type Condition
Patients Babies with symptom of hypopigmented patches
with hyperpigmented border without any
structural changes in any part of the body
Intervention /
Comparator Agent
Type Name Details
Intervention PARANGIPATTAI
CHOORANAM (Internal)and
ANNABEDHI CHENDURAM
(External)
PARANGIPATTAI
CHOORANAM is a single herb
formulation in a dosage of 1/2 -
1 g (b.d) for 48 days.
ANNABEDHI CHENDURAM
mixed with lime juice and
applied externally in the affected
areas
Comparator Agent NA NA
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Inclusion Criteria Inclusion Criteria
Age From 5.00 Year(s)
Age To 12.00 Year(s)
Gender Both
Details 1.Hypo pigmented patches with hyper pigmented border without any
structural changes in any part of the body.
2.Patients who are willing to stay in IPD Ward for atleast 10 days or
willing to attend OP Dept. as required.
3.Patient’s informant / Parent willing to sign the informed consent
stating that he/she will consciously stick to the treatment during 48
days but can opt out of the trial of his / her own conscious discretion.
4.Willing to cooperate for taking photographs whenever required with
hisher consent.
Exclusion Criteria Exclusion Criteria
Details 1.Albinism
2.Dermatological aspect of Leprosy
3.Tinea versicolor
4.Burn scars
5.Dermatological aspect of Addisons diseases
6.Post inflammatory hypopigmentation
7.Pityriasis alba
8.Alopecia aerate
9.Chemical leucoderma
Method of Generating
Random Sequence
Not Applicable
Method of
Concealment
Not Applicable
Blinding/Masking Not Applicable
Primary Outcome Outcome Timepoints
Efficacy of the trial drug measured by VASI
Score.
1-48 days
Secondary Outcome Outcome Timepoints
Occurrence of new lesion, anywhere else in the
body after
intake of trial medicine
3 months
Target Sample Size Total Sample Size=30
Sample Size from India=30
Phase of Trial Phase 2
Date of First
Enrollment (India)
20/06/2017
Date of First
Enrollment (Global)
No Date Specified
Estimated Duration of
Trial
Years=2
Months=0
Days=0
Recruitment Status of
Trial (Global)
Not Applicable
Recruitment Status of
Trial (India)
Not Yet Recruiting
Publication Details NIL
Brief Summary Clinical evaluation of PARANGIPATTAI CHOORANAM (Internal) and ANNABEDHI CHENDURAM
(External) for VENPULLI (Venpulli) in children.
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